Evaluating the Patient-Centeredness of Medicare Part D by Hensley, Melissa
Washington University in St. Louis
Washington University Open Scholarship
All Theses and Dissertations (ETDs)
January 2010
Evaluating the Patient-Centeredness of Medicare
Part D
Melissa Hensley
Washington University in St. Louis
Follow this and additional works at: https://openscholarship.wustl.edu/etd
This Dissertation is brought to you for free and open access by Washington University Open Scholarship. It has been accepted for inclusion in All
Theses and Dissertations (ETDs) by an authorized administrator of Washington University Open Scholarship. For more information, please contact
digital@wumail.wustl.edu.
Recommended Citation
Hensley, Melissa, "Evaluating the Patient-Centeredness of Medicare Part D" (2010). All Theses and Dissertations (ETDs). 148.
https://openscholarship.wustl.edu/etd/148
  
 
WASHINGTON UNIVERSITY IN ST. LOUIS 
George Warren Brown School of Social Work 
 
Dissertation Examination Committee: 
Edward F. Lawlor, Chair 
Timothy McBride 
Enola K. Proctor 
Ramesh Raghavan 
Paul T. Shattuck 
Bradley Stoner 
 
EVALUATING THE PATIENT-CENTEREDNESS OF MEDICARE PART D 
 
By 
Melissa Anne Hensley 
 
 
A dissertation presented to the 
Graduate School of Arts and Sciences 
of Washington University in  
partial fulfillment of the 
requirements for the degree 
of Doctor of Philosophy 
 
 
 
August 2010 
 
Saint Louis, Missouri 
 
 
 
 
ii 
 
 
 
 
 
 
ABSTRACT 
 
The implementation of the Medicare prescription drug benefit (“Part D”) has 
brought about many changes in the provision of prescription medications to adults with 
serious mental illness.  Existing research on the impact of Part D on this population, for 
the most part, examines the benefit from the perspective of the physicians who treat these 
individuals.  This research seeks to use a framework of patient-centered care to examine 
the impact of the Part D benefit on adults with mental illness, from the viewpoints of 
beneficiaries themselves and the case managers (“community support workers”) who 
serve them.  In addition, data from the Medicare Web site and the Centers for Medicare 
and Medicaid Services are used to examine the patient-centered characteristics of the Part 
D program.  The Medicare prescription drug benefit is meeting the needs of adults with 
serious mental illness, but this is largely because of the assistance that beneficiaries 
receive from community professionals.  The Medicare Part D program meets some 
expectations of a patient-centered program, but there are also definite areas for 
improvement, such as involvement of patients and information and education for 
beneficiaries. 
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CHAPTER I:  INTRODUCTION 
 
 The Medicare Prescription Drug, Improvement, and Modernization Act (MMA) 
marks the largest change in Medicare policy since its inception in the 1960s (Oliver, Lee 
& Lipton, 2004).  By introducing a prescription drug benefit (“Part D”) into the Medicare 
program, the MMA has substantially changed the way prescription medicines are 
financed not only for senior citizens, but also for those living with disabilities (Donohue, 
2005).  When the Medicare Modernization Act was passed in 2003, there was much 
uproar in the health care advocacy community concerning the effect that this new benefit 
would have on people with disabilities.  Lengthy reports were published and distributed, 
predicting turmoil and discontinuities in coverage for many Medicare beneficiaries 
(Kaiser Family Foundation, 2004; Medicare Rights Center, 2005; Medicare Rights 
Center, 2006).  There was concern among health services scholars, as well, about the 
impact of Part D implementation on poor and disabled beneficiaries (Donohue, 2005; 
Elliott et al., 2005; Avorn, 2006; Simoni-Wastila et al., 2008; Neuman & Cubanski, 
2009). 
 Significant problems were predicted in particular for adults disabled by serious 
mental illness.  Advocates predicted that the structure of the Medicare prescription drug 
benefit would lead to disruptions in coverage and difficulties in obtaining psychotropic 
medications, despite regulations specifically mandating coverage of these drugs (MRC, 
2006).  It was predicted that the switch from one state-administered benefit under 
Medicaid to multiple private plans in the Medicare Part D program would confuse many 
dually-eligible beneficiaries and complicate access (Perry, Kitchman, & Guyer, 2005; 
Avorn, 2006). 
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 The reality of what has happened since the inception of Medicare Part D is 
somewhat different, however (Duggan, Healy & Scott Morton, 2008; Shrank & Polinski, 
2009).  Research using pharmacy data and Medicare claims information has produced a 
mixed picture of the impact of Part D.  Part D has, in many cases, resulted in increased 
prescription drug utilization and has not substantially increased cost-related non-
adherence or created disruptions in coverage (Madden et al., 2008; Basu et al., 2010).  
For beneficiaries whose only health care coverage was through Medicare, Part D has 
meant assistance with prescription medications for the first time (Levy & Weir, 2009).  
Access issues remain, especially for low-income beneficiaries, as illustrated by the 
studies conducted by West et al. (2007, 2009) and Huskamp et al. (2009).  However, it is 
not clear that the switch from Medicaid to Medicare has made these problems worse 
(Reschovsky & Felland, 2009).   
Surveys of older adult (age 65 and older) beneficiaries indicate high levels of 
satisfaction with the program (Healthcare Leadership Council, 2008; Skarupski et al., 
2009).  For example, a 2008 survey of older adults found that 86% of beneficiaries stated 
that their co-payments were affordable, and 91% said that their Part D plans were a good 
value (Healthcare Leadership Council, 2008).  The qualitative data that exist show overall 
high rates of satisfaction with the Part D benefit, with few beneficiary reports of 
problems with access or coverage (Kaiser Family Foundation, 2006; Perry, Dulio & 
Cubanski, 2006; Dulio, Perry & Cubanski, 2007; Hargrave et al., 2008).  However, very 
little of this research focuses specifically on the experiences of adults with serious mental 
illness.  The papers that do address beneficiaries with serious mental illness do so from 
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the viewpoint of psychiatrists (West et al., 2007; Huskamp et al., 2009; West et al., 
2009). 
The purpose of this dissertation is to give a voice to Medicare beneficiaries with 
serious mental illness and the case managers (community support workers) who serve 
them.  More knowledge is needed about the impact of Part D on the everyday lives of 
people disabled by mental illness.  This study will provide first-hand information about 
the experiences of Medicare stakeholders with Part D, as well as interpretation of data 
provided by the Centers for Medicare and Medicaid Services.  The data obtained from 
these sources will be examined through the lens of patient-centered care, an important 
conceptual framework for 21st century health care.  Out of the many questions that arise 
in considering the impact of Part D on adults with mental illness, this study will focus on 
three in particular.  The overall goal of the three questions is to assess the degree to which 
Medicare Part D is a patient-centered policy, particularly for adults with mental illness.  
These questions will be answered using a mixed-methods approach that incorporates 
quantitative data and qualitative inquiry.  The questions to be addressed in this study are 
as follows: 
Research Question 1:  How do Part D stakeholders perceive the patient-centeredness 
of the Medicare prescription drug program? 
Research Question 2:  What elements of patient-centered care are recognized by 
stakeholders as most critical to an effective prescription drug program? 
Research Question 3:  How do the “benchmark” plans in one Midwestern state 
perform on the measures of patient-centeredness considered most crucial to 
stakeholders? 
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 This chapter will introduce the special concerns of Medicare beneficiaries with 
mental illness.  It will also provide background on the Medicare prescription drug 
program and summarize the research that has been conducted on Part D and older adults, 
as well as on Part D and persons with disabilities.  The chapter will conclude with a 
discussion of questions that have yet to be answered about the experiences of 
beneficiaries with mental illness with the Part D benefit, followed by an outline of the 
dissertation as a whole. 
A Profile of Medicare Beneficiaries with Serious Mental Illness 
People with serious mental illness make up a substantial proportion of low-
income Medicare beneficiaries.  In 2006, approximately two million of the six and a half 
million people who received both Medicare and Medicaid benefits had a serious mental 
illness (Donohue, Huskamp, & Zuvekas, 2009).  Serious mental illness is defined as a 
mental illness, such as schizophrenia or bipolar disorder, which causes disability and 
impairs normal functioning (Spaulding, Sullivan, & Poland, 2003).  The prevalence of 
mental illness is higher among dually-eligible beneficiaries than among other Medicare 
recipients (Donohue, 2006), and public funding makes up a large share of spending on 
psychiatric medications (Donohue, Huskamp & Zuvekas, 2009).  In 2006, Medicare 
financed 16 percent of spending for antidepressants, 21 percent of spending for 
antipsychotics, and 16 percent of spending for anticonvulsants (Donohue, Huskamp, & 
Zuvekas, 2009).  Mental illnesses are among the conditions that have driven the increase 
in spending on Medicare over the past two decades (Thorpe, Ogden & Galactionova, 
2010).  Because dually-eligible beneficiaries with serious mental illness are especially 
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reliant on public benefits for health care as well as income support, changes in public 
policy and program administration can disproportionately affect them (Kennedy & Tuleu, 
2007).  It can be particularly difficult for beneficiaries with mental illness to navigate 
public systems of care (Elliott et al., 2005; Kaiser Family Foundation, 2005).  However, 
well-administered public programs can also be of tremendous benefit to individuals with 
serious mental illness. 
Dually-eligible beneficiaries as a whole are more likely to have poor health status 
than higher-income beneficiaries.  They are also more likely to be members of minority 
groups and tend to have less education than higher-income beneficiaries.  These 
characteristics can create additional vulnerability to program changes, as well as the 
potential to benefit from program improvements (Elliott et al., 2005). 
Background of Medicare Part D 
Prior to 2006, dually-eligible beneficiaries with serious mental illness received 
prescription drug benefits through the Medicaid program.  In the state of Missouri, 
individuals with disabilities with incomes of less than $768 per month are eligible for the 
full Missouri HealthNet program, and some individuals with higher incomes are able to 
use the MO HealthNet Medically Needy program (Missouri Department of Social 
Services, 2010). 
Though prescription drug coverage is not a required benefit under Medicaid, all of 
the fifty states have chosen to include this benefit as a part of their Medicaid programs.  
Before the Medicare Modernization Act, people with serious mental illness who received 
SSI benefits or who bought into the Medicaid program through state Medically Needy 
(“spend-down”) programs were able to obtain their medications, for psychiatric and 
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medical conditions, at a very low cost.  For example, in the state of Missouri, co-
payments for Medicaid-covered prescriptions ranged from fifty cents to two dollars at 
most.  Some states, such as Missouri, had imposed certain utilization management tools 
on their Medicaid prescription drug benefits, in order to prevent antipsychotic poly-
pharmacy and other non-evidence-based prescribing practices (Parks & Surles, 2004).  
However, for the most part, people with serious mental illness were able to obtain the 
medicines that had been prescribed to them using their Medicaid benefits. 
This situation changed with the implementation of Medicare Part D in 2006.  
Dually-eligible beneficiaries—those who received Medicare and Medicaid benefits—
were auto-assigned to private Medicare Part D prescription drug plans, and they were no 
longer allowed to use their Medicaid benefits for most of their medications (Morden & 
Garrison, 2006).  Dually-eligible beneficiaries were automatically enrolled in stand-alone 
prescription drug plans under Part D if they did not choose a plan for themselves in the 
Fall of 2005.    Some beneficiaries (approximately 11 percent in 2008) opted to enroll in 
Medicare Advantage (Part C) plans which provided managed-care coverage not only for 
prescription drugs but also for services ordinarily covered by Parts A (inpatient) and B 
(outpatient; physicians’ services) of Medicare (Neuman & Cubanski, 2009; Donohue, 
Huskamp, & Zuvekas, 2009).  However, most dually-eligible beneficiaries with mental 
illness (89 percent) were enrolled in stand-alone, private prescription drug plans in 2008.  
Auto-enrollment was an efficient way to maximize continuity of access for dually-
eligible beneficiaries.  However, because beneficiaries were randomly assigned to basic 
prescription drug plans with low premiums, the plan to which a particular beneficiary was 
assigned was not necessarily the best “fit” in terms of formulary or pharmacy network.  
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This led to the need for some beneficiaries to switch plans to ensure that their particular 
medicines were covered and that they could use their preferred pharmacy. 
The Medicare prescription drug program is structured and administered very 
differently from state-run Medicaid programs.  Although most Medicaid prescription 
drug programs are operated through state governments, Medicare prescription drug 
benefits are administered through a variety of private insurance company plans, including 
stand-alone prescription drug plans and Medicare managed care plans (Bakk, 2009).  
Though some protections are in place to ensure that psychotropic medications are 
covered by Medicare prescription drug plans, many beneficiaries have a less 
comprehensive benefit under the Medicare program than they had under Medicaid 
(Kaiser Family Foundation, 2004).  Medicare Part D co-payments are often higher than 
co-payments under Medicaid, and because of competition among Part D plans, Part D 
plans have greater incentives to restrict their formularies or to put utilization management 
restrictions in place (Donohue, Huskamp, & Zuvekas, 2009). 
For beneficiaries who did not qualify for the low-income subsidy under Medicare 
Part D, the “doughnut hole” coverage gap was also a concern.  The Medicare Part D 
program is structured so that in 2010, Part D plans cover 75% of prescription drug 
expenses up to an out-of-pocket spending limit of $2,830 in drug costs.  Between $2,830 
and $6,440, beneficiaries are responsible for 100% of prescription drug costs.  When a 
beneficiary’s expenses are greater than $6,440, “catastrophic” coverage takes effect, and 
the Part D plan covers 95% of expenses above that amount for the rest of the year (Kaiser 
Family Foundation, 2009). 
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The low-income subsidy for Medicare Part D fortunately covered the cost of the 
Part D premium for basic plans (also called “benchmark” plans).  It also covered the 
expenses incurred by low-income beneficiaries in the “doughnut hole” coverage gap.  
Part D formularies were required by CMS regulations to cover “all or substantially all” 
drugs in several classes of medications important to those with severe mental illness, such 
as antidepressants and antipsychotics (Huskamp et al., 2007).  However, the imprecise 
definition of “substantially all” meant that some formularies did not cover certain 
medicines needed by beneficiaries, and some important medicines were placed on 
restrictive “tiers” of coverage requiring prior authorization (Donohue & Frank, 2007).  In 
addition, certain classes of drugs, such as benzodiazepines, were forbidden by federal law 
from being covered in Part D plans (Yang et al., 2008).  Co-payments are also higher 
under Part D than under Medicaid; in 2010, co-payments for low-income subsidy 
participants were $2.50 per prescription for generic drugs and $6.30 per prescription for 
brand-name drugs (Centers for Medicare and Medicaid Services, 2010). 
Anecdotal information from mental health providers has suggested that cost and 
access problems have resulted from the change in prescription drug benefits, and a recent 
survey of psychiatrists suggests that a number of patients have experienced disruptions in 
coverage which have, in some cases, led to poor mental health outcomes (West et al., 
2007; Huskamp et al., 2009; West et al., 2009).  In addition, the exclusion of 
benzodiazepines from coverage under Part D has created problems for some beneficiaries 
because disabled Medicare beneficiaries, especially those disabled by serious mental 
illness, are more likely to use this class of medicines than older adult beneficiaries (Yang 
et al., 2008).  Because dually-eligible beneficiaries are more likely to have higher 
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prescription drug costs, disruptions in access can cause major health problems (Kennedy 
& Tuleu, 2007; Simoni-Wastila et al., 2008; Riley, Levy & Montgomery, 2009). 
Information is conflicting, however.  Basu, Yin, and Alexander (2010) studied the 
impact of Part D on dually-eligible beneficiaries’ medication utilization and did not find 
evidence of disruptions in coverage or access problems.  Reschovsky and Felland (2009) 
reported that access issues existed for non-elderly Medicare beneficiaries, but that the 
switch from Medicaid to Medicare does not appear to have made this problem worse.  In 
contrast, Jacobson and Anderson (2010) reported that coverage and access problems did 
occur for dually-eligible beneficiaries during the switch from Medicaid to Medicare.  
Donohue, Huskamp, and Zuvekas (2009) examined access to prescription medicines 
among dually-eligible Part D beneficiaries with mental illness and found that there were 
fewer benchmark plans serving dually-eligible beneficiaries in 2009 than there had been 
the year before, and that some incentives existed for prescription drug plans to restrict 
access to people with mental illness through use of utilization management tools. 
The next section will provide an overview of studies that have examined use of 
Part D and Part D-related outcomes among predominantly older adult populations.  Three 
main themes will be explored. 
Impact of Part D on the Elderly 
Since 2007, a number of studies, using a variety of sources of data, have explored the 
impact of the Medicare Part D program on older adults (defined as adults aged 65 and 
over).  Three themes that appear frequently in these papers are characteristics of older 
adults who enroll in Part D; prescription drug costs and utilization among Part D 
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participants; and cost-related non-adherence following the implementation of Part D.  
The following table outlines these studies, the questions they asked, and their findings. 
Table 1.1  Studies of Part D and Older Adults 
Authors Data Source Research Question Findings 
Neuman et al. 
(2007) 
National survey of 
older adults 
Assessing how 
many older adults 
are enrolled in Part 
D; comparing out-
of-pocket spending 
and cost-related 
non-adherence 
between those with 
Part D and those 
with other types of 
prescription drug 
coverage 
Out-of-pocket 
spending and cost-
related non-
adherence were 
greater among Part 
D enrollees than 
those with VA or 
employer-sponsored 
coverage. 
Hsu et al. (2008) Survey of older 
adults with 
Medicare Advantage 
coverage in 
Northern California  
Assessment of older 
adults’ knowledge 
of their prescription 
drug benefits and 
their ways of coping 
with drug costs 
40% of participants 
were aware of the 
Part D coverage gap; 
15% reported cost-
related non-
adherence. 
Madden et al. 
(2008) 
Medicare Current 
Beneficiary Survey 
(older and disabled 
adults) 
Assessment of cost-
related non-
adherence following 
Part D 
implementation 
There was a small 
reduction in cost-
related non-
adherence among 
beneficiaries after 
Part D, but those 
with the most severe 
health problems still 
frequently reported 
cost-related non-
adherence. 
Shrank et al. (2008) Pharmacy 
dispensing data 
related to five 
classes of study 
drugs:  clopidogrel, 
proton pump 
inhibitors, warfarin, 
statins, and 
benzodiazepines 
Evaluating 
medication use, out-
of-pocket spending, 
and medication 
switching during the 
transition from 
Medicaid to 
Medicare Part D for 
older adult dual 
Medicare Part D had 
no significant effect 
on use of any of the 
drugs studied.  Co-
payments went 
down, except for 
benzodiazepines.  
Rate of switching 
drugs went up for 
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eligibles PPIs but stayed the 
same for all others. 
Yin et al. (2008) Pharmacy claims 
data 
Estimation of 
changes in older 
adults’ prescription 
drug utilization 
following Part D 
implementation 
A modest increase in 
drug utilization and 
a small decrease in 
out-of-pocket costs 
were reported. 
Zhang et al. (2008) Pharmacy claims 
data 
Assessing effect of 
Part D on generic 
drug utilization 
From 2005 to 2006, 
use of generics grew 
more slowly among 
Part D beneficiaries 
than among those 
with other kinds of 
coverage. 
Briesacher et al. 
(2009) 
Pharmacy 
dispensing data 
Calculation of 
enrollment of 
nursing home 
residents (older and 
disabled adults) in 
Part D; assessment 
of effect of Part D 
on out-of-pocket 
drug spending 
81% of nursing 
home residents were 
enrolled in Part D in 
2006.  The 
proportion of 
prescriptions for 
nursing home 
residents paid for 
out-of-pocket 
decreased from 11% 
to 8% from 2005 to 
2006. 
Fung et al. (2009) HMO claims data Calculation of 
impact of coverage 
gap on older adults 
with diabetes 
enrolled in Medicare 
Advantage 
Prescription drug 
spending and cost-
related non-
adherence were 
higher for those with 
coverage gap than 
for those without a 
gap in coverage. 
Joyce et al. (2009) Part D 
administrative data 
from CMS 
Assessment of 
impact of Part D on 
older adults’ out-of-
pocket drug 
spending and 
prescription drug 
use. 
Cost savings 
associated with Part 
D were concentrated 
among low-income 
beneficiaries.  Part D 
was associated with 
decreased out-of-
pocket spending and 
increased medication 
use. 
Levy & Weir Health & Retirement Estimation of the Take-up of Part D 
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(2009) Survey impact of Medicare 
Part D on 
prescription drug 
coverage among 
older adults and 
determine predictors 
of program 
enrollment among 
older adults with no 
prior drug coverage 
was high among 
those with no 
previous drug 
coverage.  Demand 
for prescription 
medicines was the 
biggest predictor of 
Part D enrollment. 
Pedan et al. (2009) Pharmacy 
dispensing data 
Examination of drug 
consumption 
patterns among 
older adults to 
determine which 
beneficiaries reach 
the coverage gap. 
About 1/5 of 
beneficiaries reached 
the coverage gap but 
only a small number 
of these reached 
catastrophic 
coverage levels.  
Patients with chronic 
conditions reported 
the highest drug 
consumption. 
Reschovsky & 
Felland (2009) 
2003 Community 
Tracking Study 
Household Survey; 
2007 Health 
Tracking Household 
Survey 
Exploration of 
access to 
prescription 
medicines following 
implementation of 
Part D 
There was very little 
change in older 
adults’ tendency to 
skip filling a 
prescription 
following Part D 
implementation. 
Safran et al. (2009) Longitudinal data 
from CMS 
Examining changes 
in older adults’ 
prescription drug 
use and spending as 
a result of Part D 
Those who lacked 
drug coverage in 
2003 had increased 
utilization, reduced 
out-of-pocket 
spending, and 
reduced cost-related 
non-adherence 
following enrollment 
in Part D. 
Schneeweis et al. 
(2009) 
Pharmacy 
dispensing data 
Calculating effect of 
Part D 
implementation on 
older adults who 
had lacked prior 
drug coverage 
Part D increased 
utilization, until 
beneficiaries reached 
the coverage gap, 
when utilization 
decreased. 
Skarupski et al. 
(2009) 
Cross-sectional data 
from Chicago 
Examining racial 
differences in Part D 
African-American 
older adults enrolled 
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Health and Aging 
Project, a 
population-based 
biracial survey of 
older adults 
enrollment in Part D are more 
likely to  have 
chronic health 
conditions and low 
incomes than White 
older adults in Part 
D. 
Zhang et al. 
(2009a) 
Medicare Advantage 
plan data from a 
large insurer in 
Pennsylvania 
Examination of 
whether older 
adults’ prescription 
drug spending 
following Part D 
implementation was 
associated with 
reductions in other 
medical spending 
There was an 
increase in 
prescription 
utilization but only a 
minimal offset of 
other medical costs 
in the Medicare 
Advantage program. 
Zhang et al. 
(2009b) 
Enrollment, benefits, 
and claims data from 
a large insurer in 
Pennsylvania, from 
an employer-based 
plan and an 
individual Part D 
PDP 
Comparing 
prescription drug 
usage of older adults 
in an employer 
group with no 
coverage gap with 
usage among older 
adult members of a 
Part D PDP group 
with a coverage gap 
or generic coverage 
in the gap 
More beneficiaries 
reached the 
“doughnut hole” 
level of spending in 
the plan that had no 
gap, as compared to 
the plan that had a 
gap.  Those lacking 
coverage in the gap 
reduced their 
spending on 
prescription drugs. 
Zivin et al. (2009a) Longitudinal survey 
data from the Health 
and Retirement 
Survey 
Calculation of rates 
of enrollment in 
Medicare Part D by 
older adults with 
depression and 
cognitive 
impairment 
Older adults with 
depression and 
cognitive 
impairment were 
more likely than 
other beneficiaries to 
sign up for a Part D 
plan. 
Zivin et al. (2009b) Medicare Current 
Beneficiary Survey  
Calculation of cost-
related non-
adherence among 
beneficiaries with 
depression 
following 
implementation of 
Medicare Part D 
Cost-related non-
adherence did not 
decline among 
beneficiaries with 
depressive 
symptoms relative to 
those without 
depressive 
symptoms. 
Basu et al. (2010) Pharmacy claims Examination of the The implementation 
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data effect of Part D on 
dually-eligible older 
adults’ prescription 
drug use and 
expenditures 
of Part D had no 
effect on dually-
eligible 
beneficiaries’ use of 
prescription 
medicines or their 
expenditures on 
medicines. 
Maciejewski et al. 
(2010) 
Medicare Current 
Beneficiary Survey 
Examining patient 
factors and 
medication 
acquisition 
strategies impacting 
enrollment in 
prescription drug 
plans among 
beneficiaries with 
no prior drug 
coverage. 
Older adults without 
prior drug coverage 
were more likely to 
enroll in Part D if 
they were younger 
(age 65-74), female, 
non-Hispanic white, 
or married or 
widowed.  A greater 
number of self-
reported medical 
conditions was also 
associated with 
enrollment in Part D. 
 
Beneficiary Enrollment 
 The literature on characteristics of beneficiaries who enroll in Part D tends to 
indicate that more vulnerable groups of beneficiaries were actually more likely to sign up 
for Medicare Part D than healthier, higher-income beneficiaries (Levy & Weir, 2009; 
Skarupski et al., 2009; Zivin et al., 2009a).  Maciejewski et al. (2010) found that 
beneficiaries with greater numbers of self-reported health conditions were more likely to 
enroll in Medicare Part D than beneficiaries who reported themselves to be healthier. 
Utilization and Costs 
 The evidence on the effect of Part D on utilization and costs is mixed.  It seems 
that beneficiaries who had no drug coverage prior to Part D tend to experience increased 
utilization as well as decreased costs (Yin et al., 2008; Joyce et al., 2009; Safran et al., 
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2009).  For dually-eligible beneficiaries, who had Medicaid drug coverage prior to Part 
D, implementation of the Medicare drug benefit seems to have had little impact on costs 
or utilization (Basu et al., 2010). 
Cost-Related Medication Non-Adherence 
Cost-related non-adherence also varies according to whether a beneficiary had 
coverage prior to Part D.  Among those who had no coverage before Part D, cost-related 
non-adherence tended to go down following Part D implementation (Madden et al., 2009; 
Safran et al., 2009).  For beneficiaries with depressive symptoms who enrolled in Part D, 
cost-related medication non-adherence stayed about the same (Zivin et al., 2009b).  
Beneficiaries who entered the “doughnut hole” coverage gap were more likely to report 
non-adherence (Fung et al., 2009; Zhang et al., 2009b). 
Overall, older adults expressed satisfaction with the Part D program, and they 
reported few problems with access and cost.  Cost-related non-adherence went down 
among those who had not had prior prescription drug coverage, and it tended to stay the 
same for other beneficiaries.  There appears to have been some adverse selection of 
sicker people into Part D plans.  An important question to consider is whether the same 
assertions can be made for younger Medicare beneficiaries with disabilities, and whether 
their situations might differ substantially from elderly program participants. 
Impact of Part D on Individuals with Disabilities 
Relatively little attention has been directed toward studying the effects of Part D 
on beneficiaries with disabilities.  Beneficiaries with disabilities are defined as Medicare 
beneficiaries under age 65 who have a diagnosis that prevents them from being able to 
maintain employment (Hall, Kurth, & Moore, 2007).  Of those studies that have 
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examined the impact of Part D on this population, most have looked specifically at 
beneficiaries with serious mental illness.  Studies of Part D and individuals with 
disabilities have rarely surveyed beneficiaries themselves, instead relying on other 
informants and sources of information. 
Stuart, Simoni-Wastila and Chauncey (2005) used data from the Medicare 
Current Beneficiary Survey from 1998-2000 to predict the impact of coverage gaps on 
individuals with chronic illness, specifically diabetes, chronic lung disease, and mental 
illness.  They predicted that beneficiaries who have these chronic conditions but are not 
eligible for the low-income subsidy would have a higher-than-average likelihood of 
reductions in medication use and drug spending during the “doughnut hole” coverage 
gap.  Because medication therapy is often very important in managing chronic illness, 
Stuart et al. (2005) noted that this sensitivity to costs could have an adverse impact on 
patients’ health. 
Hall, Kurth, and Moore (2007) found that many younger dually-eligible 
beneficiaries with a variety of disabilities had experienced disruptions in coverage as well 
as difficulties with the information provided by the Centers for Medicare and Medicaid 
Services and their prescription drug plans.  The two main problems that Hall et al. found 
were difficulties in accessing needed medications and insufficient knowledge of program 
rules.  Beneficiaries commonly switched plans because they were unable to obtain the 
medications that they needed, yet over half of beneficiaries surveyed did not know how 
often they were allowed to change Part D plans. 
Donohue and Frank (2007) examined the rate of medication switching that was 
occurring among dually-eligible beneficiaries with mental illness as a result of formulary 
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restrictions in Part D.  They found that a relatively small percentage of beneficiaries (2 to 
10 percent, depending on the class of drug) had switched medications as a result of 
formulary restrictions and utilization controls.  Most dually-eligible beneficiaries 
experienced continuity of prescribed medication under the Part D benefit.   
West, et al. (2007) surveyed almost six thousand psychiatrists in order to assess 
the impact of Part D on dually-eligible beneficiaries with mental illness.  They found that 
a little over half of the psychiatrists reported that at least one patient had experienced a 
medication access problem.  Among the patients who had had access problems, about 
one-quarter had had a “significant adverse clinical event” such as a trip to the emergency 
room or an inpatient hospitalization (West et al., 2007, p. 789).  A little less than ten 
percent of psychiatrists reported that patients had experienced improved medication 
access as a result of Part D.  
Wilk, et al. (2008) studied the administrative burden of Part D participation on the 
psychiatrists of dually-eligible Medicare beneficiaries.  They found that in many cases, 
psychiatrists spent one hour on prescription drug-related administrative tasks for every 
one hour spent in direct client contact.  Administrative tasks included facilitating prior 
authorizations for the use of certain prescription drugs, as well as other tasks related to 
obtaining medicines for dually-eligible patients.  This paperwork burden could 
discourage psychiatrists from treating dually-eligible patients; it could also have 
implications for quality of care delivered to these patients, as psychiatrists are less and 
less able to devote sufficient time to face-to-face clinical care. 
Huskamp et al.(2009) also surveyed psychiatrists who treated dually-eligible 
patients.  They found that during the 2006 calendar year, 44% of the patients reported on 
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by these psychiatrists had experienced some sort of access problem related to Part D.  
Access problems were associated with increased use of the emergency room for 
psychiatric treatment, but not with increased inpatient hospitalization. 
West et al. (2009), using data provided by psychiatrists treating dually-eligible 
patients, also examined access problems among dually-eligible beneficiaries with mental 
illness.  Their findings were similar to Huskamp et al (2009); 43.3% of dually-eligible 
patients for whom data were provided had experienced access problems with prescription 
drugs during 2006.  Part D plans’ use of utilization management tools, such as step 
therapy, prior authorization, and quantity limits, were associated with access problems.  
Access problems were associated with an increased risk of adverse events such as 
emergency room visits and increases in suicidal behavior. 
Yang et al. (2009) examined non-adherence to prescription medicine regimens 
among Part D enrollees with diabetes in six states.  They looked at data from both older 
adult beneficiaries and younger adult beneficiaries with disabilities.  Yang et al. found 
that beneficiaries who were under age 65, as well as women, black, or Hispanic patients, 
were less likely to be adherent to medications for glycemic control and for cardiovascular 
complications of diabetes. 
Many beneficiaries with disabilities have experienced very little disruption in 
their prescription drug benefits as a result of the implementation of Part D (Donohue & 
Frank, 2007).  However, some disabled beneficiaries, particularly those with mental 
illness, have experienced interruptions in coverage as well as cost and access problems 
that have resulted in clinically significant problems (West et al., 2007; West et al., 2009; 
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Huskamp et al., 2009).  In addition, insufficient knowledge of plan rules and guidelines 
appears to be a barrier to utilization of benefits (Hall, Kurth, & Moore, 2007).  
Questions that Remain 
There needs to be a more thorough examination of the impact of Medicare 
prescription drug coverage on the lives of people with severe mental illness.  We do not 
fully understand how Part D has changed the health and health care of individuals with 
psychiatric disabilities, particularly those with low incomes.  We especially lack an 
understanding of how well the Medicare prescription drug benefit is meeting the unique 
needs of beneficiaries who have mental illness.  As policy-makers focus more and more 
on health reforms that are “consumer-directed” and “patient-centered” (Benjamin & 
Fennell, 2007), we will need a more in-depth knowledge of the capacity of this new 
Medicare benefit to address the financial and other challenges that individuals with 
psychiatric disabilities face. 
Some of the questions that remain to be answered regarding the impact of Part D 
on beneficiaries with mental illness include the following. 
What constitutes a true and accurate picture of the effect of the Medicare 
prescription drug program on disabled adults with mental illness?   
How have Medicare beneficiaries with mental illness made use of this new 
program, and what have their experiences been?   
What is an appropriate conceptual framework with which to examine these 
questions? 
What has been the impact of changes in co-payments on beneficiaries’ ability to 
obtain the medications they need? 
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How have variations in formulary inclusiveness among plans affected 
beneficiaries’ continuity of care? 
What sources of information do beneficiaries with mental illness rely on to 
understand and utilize their Part D benefits? 
Who helps beneficiaries with mental illness to negotiate the paperwork and 
service systems associated with the Part D benefit? 
How good is the “fit” between the attributes of Medicare prescription drug plans 
and the specific needs of beneficiaries with mental illness? 
To assess the performance of the Medicare Part D program, it is helpful to 
consider the needs of beneficiaries as the first priority.  Health reform initiatives of the 
last ten or fifteen years have frequently emphasized the importance of patient-centered 
care—care that is focused on the needs and wishes of the patient, rather than the 
convenience of the care provider (Gerteis et al., 1993).  This idea is somewhat late in 
coming to the mental health sector (Borg et al., 2009; Pincus et al., 2007).  Nonetheless, 
the notion of patient-centered care is one that can be used to assess the impact of Part D 
coverage on people with severe mental illness.  This study will use the framework of 
patient-centered care, as developed by the Picker Institute, to evaluate how well Medicare 
prescription drug coverage is meeting the needs of this very vulnerable group of 
beneficiaries.  It will examine the impact of the Medicare prescription drug benefit on 
adults with mental illness, and attempt to understand what has gone well for these 
beneficiaries, as well as what may have gone wrong.  It will examine not only whether 
beneficiaries are satisfied with the Part D program, but also why. 
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 This dissertation aims to address in a more comprehensive way some of the 
questions surrounding mentally ill beneficiaries’ use of the Part D benefit.  
Methodological triangulation—using both qualitative and plan comparison data—is 
employed (Speziale & Carpenter, 2005).  Qualitative data from two distinct groups of 
Medicare stakeholders, both beneficiaries and their community-based case managers, are 
examined and analyzed.  In addition, plan comparison data from www.medicare.gov and 
Medicare Part D Performance Data are considered.  The conceptual framework of 
patient-centered care is used as a way to organize the questions asked of the data, and as a 
way to understand the results obtained. 
Chapter 1 has provided an introduction to the Medicare Part D program and an 
outline of the study.  Chapter 2 offers an explanation of the conceptual model being used 
and reviews the patient-centered care literature from a variety of disciplines.  Chapter 3 is 
an overview of the research design and methods.  Chapter 4 describes the results of the 
qualitative and plan comparison data.  Chapter 5 provides a discussion of the results and 
their application to patient-centered care, as well as implications of the findings for 
research, policy and practice, and social work education. 
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CHAPTER II:  CONCEPTUAL MODEL:  PATIENT-CENTERED CARE 
Introduction 
Patient-centered care is a concept that is used in the health services literature to 
describe health care that is guided by the needs and values of the patient, rather than the 
health care system, organization, or professional (Institute of Medicine, 2001).  It has 
been used as a framework for evaluation of health care services and for proposing reform 
of the health care system.  Patient-centered care (also called person-centered, client-
centered, or patient-focused care) has been adopted as an ideal of practice in a number of 
health care professions, including medicine, nursing, occupational therapy, and 
rehabilitation (Mead & Bower, 2000; Radwin et al., 2009; Sumsion, 2005; Leplege et al., 
2007).  This chapter will discuss the origins of the patient-centered care concept and the 
use of this idea in health services research and policy, including its use in mental health.  
The use of patient-centered care in health research, as a dependent variable and as an 
independent variable, will be reviewed.  This chapter will also outline the use of patient-
centered care as a method for evaluating health care systems and programs and describe 
this investigator’s framework for evaluating the patient-centeredness of the Medicare Part 
D program.   
Use of the Term, “Patient-Centered Care” 
“Patient-centered care” is a term that has its origins in conceptual writings from 
the 1960s (Balint, 1969; Balint, Ball & Hare, 1969).  Enid and Michael Balint, 
psychoanalysts from Great Britain, conducted  seminars for primary care practitioners 
and medical students in which they taught physicians to “examine the whole person” 
(Balint, 1969, p. 269) instead of looking only at physical symptoms of illness.  The 
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original aim of patient-centered care was to integrate psychotherapeutic methods into 
medical practice so that psychological causes of illness would be more likely to be 
discovered and explored (Balint et al., 1969). 
Patient-centered care was introduced as a clinical method for primary care 
physicians in the mid-1980s, by several physician-researchers in Canada and South 
Africa (McCracken et al., 1983; Levenstein et al., 1986).  These physicians believed that 
patient-centered medicine was a set of skills that could be taught to family practitioners, 
to help them to consider the patient’s experience and definition of illness as well as the 
“pathological diagnosis” (Levenstein et al., 1986, p. 24).  They believed that to provide 
adequate and appropriate primary care services, the practitioner needed to understand the 
patient’s emotional needs. 
Patient-centered care was introduced to the health services research field in the 
late 1980s by the Picker/Commonwealth Program for Patient-Centered Care, now the 
Picker Institute (Picker Institute, 2008).  The Picker/Commonwealth Program produced a 
volume entitled Through the Patient’s Eyes, which proposed reform of health care in the 
United States, based on eight principles which they identified as constituting patient-
centered care (Gerteis et al., 1993).  Those principles are as follows: 
1. Respect for the patient’s values, preferences, and expressed needs:  This involves 
including patients in decision-making processes to ensure that treatments that are 
chosen are congruent with the patient’s values and preferences.  It means that 
patients need to have options available to them that are in line with their values 
and preferences.  It also involves defining needs according to the patient’s 
perspective, rather than the health care provider’s opinion of what the patient 
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needs.  This principle of patient-centered care also includes sensitivity to a 
patient’s cultural values and the impact those values may have on his/her 
perceptions of health care processes. 
2. Information and education.  This means that patients need information about their 
diagnosis and prognosis, as well as education about treatment options that are 
available.  They also need information about how health care organizations and 
programs work so that they can use them effectively. 
3. Access to care.  Patients need to be able to get timely appointments and need to be 
able to obtain care in a location that is convenient for them.   Access can also 
involve affordability of care; patients must be able to pay for their care in order 
for it to be accessible. 
4. Emotional support to relieve fear and anxiety.  Patients need emotional support 
from providers to help them address fear and anxiety associated with diagnosis 
and treatment of their condition.  Emotional support can be just as empowering as 
involvement in treatment decisions, according to the Picker Institute (2010). 
5. Involvement of family and friends.  Patients should be permitted to involve family 
and friends in decisions about treatment as well as processes of care. 
6. Continuity and secure transitions between health care settings.  The process of 
being referred or transferred from one source of care to the next should operate 
seamlessly, with the patient being able to switch providers or programs free of 
interruptions in care. 
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7. Physical comfort.  Patients should receive assistance with pain management and 
maintaining physical comfort.  Physical comfort can also involve assistance with 
activities of daily living. 
8. Coordination of care.  Providers should communicate with each other so that 
services operate in a coordinated way.  Providers from different disciplines or 
offering different services should coordinate their efforts so that patients 
experience care in a less confusing, more continuous way. 
 (Audet, Davis & Schoenbaum, 2006; originally from Gerteis et al., 1993; Picker 
Institute, 2010). 
From this basic definition of patient-centered care developed in the early 1990s, 
many other iterations of the patient-centered care concept have arisen.  “Patient-centered 
care” has continued to be used both in the health services research literature and in the 
government- and privately-sponsored literature on health care quality.  Many different 
organizations and researchers have promoted patient-centered care as an ideal for which 
the health care system should strive.   
Unfortunately, there is little agreement about the definition of patient-centered 
care.  A variety of attributes of quality health care have been labeled as patient-centered, 
including respect for patients’ preferences, adequate access to care, patient empowerment 
through information and education, offering patients choices among treatments, attractive 
physical design of health care settings, and palatable food choices.  Hobbs (2009) points 
out that this lack of conceptual clarity has made it difficult to conduct meaningful 
research on attributes of patient-centered care.  Leplege et al. (2007) discuss the fact that 
it is difficult to reduce patient-centered care to a single idea because the concept of 
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patient-centered care is inherently anti-reductionist.  Nonetheless, additional clarity 
regarding the use of the term patient-centered care would be helpful to researchers and 
policy-makers. 
Saha, Beach and Cooper (2008) mention the development of patient-centered care 
from a concept used to describe a particular clinical method to a set of characteristics of 
health care systems and organizations.  This evolution can be seen in the development 
and promotion of many different definitions of patient-centeredness, which are outlined 
below.  The table below provides a summary of some of the major definitions of patient-
centered care, including information on the aspect of the health care process described 
and the profession addressed by the definition.  “Clinical method” refers to interpersonal 
processes between providers and patients.  “Processes of service provision” includes 
communication between provider and patient but includes other aspects of the process of 
health care delivery.  “Health care organizations” involves organization, system, and 
policy processes and their impact on the patient.  Application of each definition to system 
and organizational issues—clinical definitions as well as those involving processes and 
organizations—is discussed. 
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Table 2.1  Patient-Centered Care Definitions 
Authors or 
organizations 
promoting 
definition 
Aspect of the 
health care 
process 
described 
Profession Dimensions of the definition Application to 
health care 
systems and 
programs 
Picker Institute 
(Gerteis et al., 
1993) 
Processes of 
service 
provision 
Not specified Respect for the patient’s values, 
preferences, and expressed needs. 
Information and education. 
Access to care. 
Emotional support to relieve fear 
and anxiety. 
Involvement of family and 
friends. 
Continuity and secure transition 
between health care settings. 
Physical comfort. 
Coordination of care. 
Access, secure 
transition, and 
care 
coordination 
are all 
potentially 
system 
attributes. 
Law, Baptiste 
& Mills (1995) 
Clinical 
method 
Occupational 
therapists 
Individual autonomy and choice 
Partnership 
Therapist and client responsibility 
Enablement 
Contextual congruence 
Accessibility 
Respect for diversity 
Contextual 
congruence and 
accessibility 
are program 
characteristics. 
Bechel, Myers 
& Smith 
(2000) 
Processes of 
service 
provision 
Not specified Involving the patient in treatment 
decisions 
Increasing patient communication 
with providers and patient 
understanding of what to expect 
from treatment plans, recovery, 
and aftercare 
Involving family members in care 
Mentions the 
importance of 
patient 
involvement in 
decision-
making 
Mead & Bower 
(2000) 
Clinical 
method 
Physicians Biopsychosocial perspective 
“Patient-as-person” 
Sharing power and responsibility 
Therapeutic alliance 
“Doctor-as-person” 
“Patient-as-
person” and 
power-sharing 
dimensions can 
be applied to 
the structure 
and operation 
of health care 
programs 
Institute of 
Medicine 
(2001) 
Processes of 
service 
provision 
Not specified Coordination and integration 
Provision of information and 
education to  patients 
Attention to physical comfort 
Emotional support 
Involvement of family and friends 
Care 
coordination 
and provision 
of information 
and education 
to patients can 
be program or 
system 
characteristics. 
Little et al. 
(2001) 
Clinical 
method 
Physicians Exploring the experience and 
expectations of disease and illness 
Partnership 
between 
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Understanding the whole person 
Finding common ground 
regarding management 
(partnership) 
Health promotion 
Enhancing the doctor-patient 
relationship 
Realistic use of time 
providers and 
patients can be 
a program- or 
system-level 
approach to 
service 
provision. 
Berry, Seiders 
& Wilder 
(2003) 
Processes of 
service 
provision 
Physicians Availability 
Appropriateness 
Preference 
Timeliness 
Mentions the 
importance of 
restructuring 
delivery 
systems to 
facilitate 
patient-
centered 
access. 
Planetree 
Alliance 
(Frampton, 
Gilpin & 
Charmel, 
2003) 
Clinical 
method 
Inpatient care 
teams 
Healing human interactions 
Patient and family education 
Involvement of patient’s support 
network 
Nurturing through food 
Addressing spiritual needs of 
patients 
Human touch 
Use of arts in healing 
Alternative and integrative 
medicine 
Innovations in architecture and 
design 
Emphasizes 
patient 
participation in 
care decisions. 
Sumsion 
(2005) 
Clinical 
method 
Occupational 
therapists 
Provide information to enable 
choice 
Participate in negotiating goals 
Overcome fear 
Mentions 
clients’ 
appreciation of 
programs that 
respect their 
needs. 
Bergeson & 
Dean (2006) 
Health care 
organizations 
Physicians Improving access to and 
continuity with clinicians 
Increasing patients’ participation 
in care 
Supporting patient self-
management 
Establishing more efficient and 
reliable mechanisms for 
coordinating care 
Addresses 
structures of 
care provision 
and health care 
organizations 
Scholle et al. 
(2006) 
Health care 
organizations 
Physicians Ease of obtaining information 
Swiftness of practitioner response 
to patient inquiries 
Referral to educational 
opportunities 
Availability of care management 
Addresses 
structures of 
care provision 
and health care 
organizations. 
International 
Alliance of 
Patients’ 
Organizations 
(2007) 
Clinical 
method and 
health care 
organizations 
Not specified Respect. 
Choice and empowerment. 
Patient involvement in health 
policy. 
Access and support. 
Stresses patient 
involvement in 
health policy. 
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Information. 
Leplege et al. 
(2007) 
Clinical 
method 
Rehabilitation 
professionals 
Addressing the person’s specific 
and holistic properties 
Addressing the person’s 
difficulties in everyday life 
The person is an expert; 
participation and empowerment 
Respecting the person ‘behind’ 
the impairment or the disease 
Emphasizes 
participation 
and 
empowerment. 
Robert Graham 
Center for 
Policy Studies 
in Family 
Medicine and 
Primary Care 
(2007) 
Processes of 
service 
provision 
Physicians Personal physician 
Physician-directed medical 
practice 
Whole person orientation 
Care is coordinated and/or 
integrated 
Quality and safety 
Enhanced access 
Payment reform 
Discusses 
reform of 
payment 
system; stresses 
enhanced 
access and 
coordinated 
care. 
Shaller (2007) Health care 
organizations 
Not specified Education and shared knowledge 
Involvement of family and friends 
Collaboration and team  
management 
Sensitivity to non-medical and 
spiritual aspects of care 
Respect for patients’ needs and 
preferences 
Free flow and accessibility of 
information 
Applies 
patient-
centered care 
principles to 
health care 
organizations. 
Saha, Beach & 
Cooper (2008) 
Clinical 
method and 
health care 
organizations 
Not specified Within healthcare organizations:  
Services aligned to meet patient 
needs and preferences, e. g.,  
1.  
Coordinated/integrated/continuous 
2.  Convenient/easily accessible 
3.  Attendant to health promotion 
and physical comfort. 
Within interpersonal interactions:  
Provider understands each patient 
as a unique human being, e. g., 
1.  Uses biopsychosocial 
model 
2. Views patient as person 
3. Shares power and 
responsibility 
4. Builds effective 
relationship 
5. Maintains and is able to 
convey unconditional 
positive regard 
6. Is aware of the “doctor as 
person” 
Stresses access 
and service 
coordination as 
important 
system 
characteristics. 
Radwin et al. 
(2009) 
Clinical 
method and  
health care 
organizations 
Nursing Responsiveness 
Individualization 
Coordination 
Proficiency 
Patient advocacy 
Patient 
advocacy is 
included in the 
model. 
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Patient-Centered Care in Mental Health 
Patient-centered care has been promoted as a useful approach to the management 
of chronic illnesses, because it values patient preferences and stresses the involvement of 
patients in decision-making about care.  This idea may have utility in the mental health 
sector, in particular.  Sharfstein and Dickerson (2006) point out that mental illnesses can 
be particularly costly over the long-term, not just in terms of health care expenses, but 
also in terms of the impact on the patient’s sense of self.  Patient-centered care processes 
may be helpful in restoring control and self-esteem to individuals with serious mental 
illness. 
The Institute of Medicine report on improving mental health and substance abuse 
care (2006) gives priority to the idea of patient-centeredness as a framework for reform of 
the mental health system.  Principles such as respect for patients’ values, preferences and 
expressed needs; information and education; and emotional support and alleviation of 
fear and anxiety; are quite relevant to mental health services.  Too often in the past, 
activities such as assessment and treatment planning in the mental health sector have 
centered on professionals’ perceptions of patient needs rather than on the priorities of the 
patient him/herself (Starnino, 2009).  A shift to patient-centeredness would serve to 
empower patients to make their own choices. 
Despite the potential that patient-centeredness holds, and despite the mention of 
patient-centeredness in the IOM report, this notion has been used very little in the mental 
health literature.  The President’s New Freedom Commission on Mental Health (2003) 
put forward as one of its goals the idea that mental health care should be “consumer and 
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family driven” (p. 27); however, it does not appear that this criterion is being widely-used 
to evaluate mental health programs.    There are concepts such as shared decision-making 
(Schauer et al., 2007) and certain uses of the terms “empowerment” and “recovery” that 
mirror the values of patient-centered care (Salyers & Tsemberis, 2007).  Empowerment in 
the community mental health field is frequently used to describe treatment-planning 
processes that are driven by the client, rather than determined by the mental health 
professional (Corrigan, 2003).  Similarly, recovery is seen as a process of healing from 
mental illness that the person with the illness directs (Starnino, 2009).  However, the 
actual term patient-centered care is rarely used in the mental health literature (IOM, 
2006).  Leplege et al. (2007) discuss the fact that the field of psychiatric rehabilitation 
embodies many of the ideas involved in patient-centered care, and they note that 
psychiatric rehabilitation scholars and practitioners have seemed to avoid the use of the 
term patient-centered care even though they are in agreement with many of its main 
concepts. 
Mechanic (2007), in his editorial on the state of psychiatric services in the United 
States, emphasized the importance of patient-centered mental health care, but it appears 
that the implementation of patient-centered care principles in mental health is still in its 
early stages.  Pincus et al. (2007) discuss the fact that the mental health service delivery 
system in the United States needs to increase its focus on the needs and preferences of 
patients, as well as involvement of family and friends in decision-making processes.  
Pincus and his colleagues also mention that the profession of psychiatry needs to let go of 
some of its control to allow patients’ ideas about appropriate care to carry more weight.   
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The concept of “personalized medicine” has gained increasing popularity in 
psychiatry in recent years (de Leon, 2009).  Personalized medicine refers primarily to the 
tailoring of pharmacological treatments to individual patients using genetic and other 
types of biological information (Moller & Rujescu, 2010).  Personalized medicine shares 
with patient-centered care the notion that communication with patients is of critical 
importance to appropriate provision of care.  Several writers who describe the use of 
personalized medicine in mental health discuss the primacy of effective provider-patient 
communications (de Leon, 2009; Koslow, Williams, & Gordon, 2010). 
Wills and Holmes-Rovner (2006) also discuss the adoption of patient decision-
making processes that respect patients’ preferences.  Shared decision-making has become 
an increasingly common element of innovative mental health programs.  In their review 
paper, Adams and Drake (2006) discuss the use of shared decision-making in mental 
health services and point out the association between adoption of shared decision-making 
practices and positive outcomes such as decreased symptom burden and increased 
satisfaction with services.  Swanson, Bastani, Rubenstein, Meredith, and Ford (2007) also 
make the connection between use of shared decision-making in depression care and 
increased patient satisfaction.  Shared decision-making is a practice that fits well with 
several patient-centered care principles, including information, communication, and 
education. 
The term “person-centered care” has recently become more widely used to 
discuss delivery of mental health care that respects patient preferences; Borg et al. (2009) 
report on two programs that exemplify what they call “person-centered care”; one of 
these is a U. S. program, and the other is a mental health service innovation from Finland. 
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Patient-centered care has the potential to reduce stigma in patient-professional 
relationships, as well.  By increasing the level of information and education that patients 
have, patient-centered care promotes empowerment and choice (Picker Institute, 2010).  
Program approaches such as teaching skills of independent living and management of 
mental health symptoms give mental health clients more control over their services and 
can increase self-direction (Starnino, 2009).  Use of these principles in service delivery 
can not only decrease self-imposed stigma among mental health patients, but it can also 
reduce the negative opinions that professionals  may have of mental health patients, by 
encouraging them to be more honest and respectful (Corrigan, 2003). 
Patient-centered care may have utility as a guide to provider-patient interactions 
in the mental health sector as well as program- and system-level reforms.  Cott (2004) 
discusses the importance of “the expertise of the client” (p. 1411) in designing 
rehabilitative services.  Starnino (2009) further explores “increased emphasis on 
mutuality in the client-worker relationship” (p. 827) as an integral part of recovery-
oriented service provision.  Actions can be taken at all levels of the care process to give 
increased voice to patients’ concerns and introduce patients’ perspectives into decision-
making processes. 
Empirical Research Using Patient-Centered Care 
 Given the volume of commentary related to patient-centered care and the 
frequency with which patient-centered care is invoked as an ideal for health care 
professionals and systems, there is a surprisingly small amount of empirical research that 
uses measures of patient-centered care.  There are a few studies that use patient-centered 
care as a dependent variable, examining the impact of certain health care practices and 
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organizational characteristics on perceptions of patient-centered care.  Patient-centered 
care has also been used as an independent variable, to assess the effect of patient-centered 
care practices on certain kinds of health care outcomes.  Both types of research are 
important in advancing an understanding of the significance of patient-centered care for 
clinical practices and health care organizations. 
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Patient-Centered Care as a Dependent Variable 
There have been several studies that have examined the factors which contribute 
to a perception of patient-centeredness in health care.  The methodology used in these 
explorations has varied, including survey methods and qualitative interviewing.  In 
addition, several different sites of care have been examined, including outpatient settings 
and acute care. 
One of the earliest examinations of factors that contribute to patient-centered care 
was the Picker-Commonwealth Survey of Patient-Centered Care (Cleary et al., 1991).  In 
this survey, adult patients who had recently been discharged from the hospital were 
surveyed regarding their perceptions of hospital practices contributing to patient-
centeredness.  For many of the questions, patients indicated a high level of satisfaction; 
for example, few patients reported problems with physical care.  However, on questions 
related to trust and relationships with physicians and hospital staff, there was more 
variation in responses, indicating that hospital staff needed to do more to build trust with 
patients. 
Another study which used Picker-Commonwealth surveys to examine the quality 
of hospital care was Gooding et al. (1999).  Patients who had recently left the hospital 
were asked questions about the occurrence of various patient-centered practices.  A fairly 
low percentage of patients reported problems with physical comfort, but a higher 
proportion of patients reported problems during their hospitalization with receiving 
emotional support and information/education. 
Little et al. (2001a) explored patients’ preferences for physicians’ use of the 
patient-centeredness outcomes of communication, partnership, and health promotion, as 
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well as patients’ desire for a prescription or a physical examination.  They found that 
patients expressed a strong desire for physicians to use patient-centered approaches in 
their consultations, stronger than their desire to receive a prescription or a physical exam. 
The Commonwealth Fund undertook a national survey of primary care and 
specialty care physicians in 2003 to assess the extent to which patient-centered care was 
practiced by U. S. physicians (Audet, Davis, & Schoenbaum, 2006).  Certain patient-
centered care practices, such as care delivered by multidisciplinary teams and efforts to 
share medical records with patients, were supported broadly by most physicians.  
However, other practices, such as using e-mail to communicate with patients and eliciting 
systematic feedback from patients, had been less widely adopted. 
Smith, Mitchell & Bowler (2007) reviewed studies of asthma education materials 
to assess the patient-centeredness of these educational programs.  They associated 
patient-centeredness with learner-centeredness in the educational context.  They found 
that most asthma education materials did not meet expectations of patient-centeredness. 
Sumsion and Law (2006) conducted a literature review in which they examined 
articles concerning client-centered practice in health care.  They sought to identify 
common elements of the various definitions of client-centered care.  They found that 
factors which contribute to client-centeredness included listening and communicating, 
partnership, hope, and choice.  Sumsion and Lencucha (2007), in a qualitative study 
interviewing occupational therapists, explored client-centered collaboration in 
occupational therapy practice.  The occupational therapists who were interviewed 
identified several actions and attributes that contribute to client-centeredness:  these 
include negotiation, advocacy, and partnership. 
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The role of certain factors in the delivery of patient-centered education efforts has 
also been examined (Zubialde, Eubank & Fink, 2007).  Zubialde, Eubank and Fink 
described patient-centered education as an outcome of the use of adult learning models, 
stressing such characteristics as humanities skills, caring, and self-directed learning skills. 
Helitzer et al. (2010) conducted a randomized controlled trial in which patient-
centered communication was the outcome variable.  They examined the effects of 
communication training on primary care providers’ patient-centered communication 
skills, and they found that training did significantly increase providers’ abilities in this 
area.  Furthermore, when the providers’ communication skills were assessed two years 
after the training, their increased capacity to provide patient-centered communication had 
persisted. 
Patient-Centered Care as an Independent Variable 
Patient-centered care has also been examined as a health care process leading to 
certain kinds of health and patient-satisfaction outcomes.  Some studies have shown 
significant associations between the adoption of patient-centered care practices and 
improved health care outcomes.  Other studies are less conclusive. 
An early study of patient-centered care as an independent variable was conducted 
by Henbest and Stewart (1990), who examined the association of patient-centered care 
with improved patient outcomes.  They found that the physician’s use of patient-centered 
care was associated with the patient’s perception that the doctor understood his or her 
concern, and with the perception that his or her concern had been resolved. 
In a study of patient-centered care in diabetes management, Kinmonth et al. 
(1998) implemented a training program in patient-centered communication for nurses and 
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general practitioners working in southern England.  They found that patients whose 
providers had completed the training were more satisfied with their communication with 
their doctors and had greater satisfaction with treatment than the patients in the 
comparison group.  However, patients whose providers had completed patient-centered 
care training had higher body mass indices and higher triglyceride levels.  Kinmonth et 
al. theorized that these patients’ indicators of physical health had not improved despite 
good communication with their physicians because physicians, in their desire to make a 
positive connection with their patients, had not been as confrontational as usual in 
addressing issues such as diet, exercise, and weight loss.  In sharing the implications of 
their study, Kinmonth et al. stressed that focusing on patients’ psychological well-being 
should not preclude discussion of important health and preventive behaviors with 
patients. 
Bechel, Myers, and Smith (2000) examined the implementation of patient-
centered care in the inpatient setting.  They defined patient-centered care using the Picker 
Institute dimensions.  Using data from 20 acute care hospitals in Michigan, they 
determined that patient-centered care was significantly associated with better patient 
outcomes in terms of mortality and complications.  However, patient-centered care was 
also associated with increased costs of providing care.  Bechel et al. suggested, however, 
that these increased inpatient costs might be compensated for later in the care process, as 
more healthy patients required less outpatient follow-up in the community following their 
hospitalizations. 
Stewart et al. (2000) examined the association of patient-centered communication 
in outpatient encounters with health outcomes and patients’ perceptions of their health 
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status.  They found that adherence to expectations of patient-centered care was associated 
with improved health status and increased efficiency in the care encounter.  Patients who 
felt that they had been treated in a patient-centered manner during the encounter with the 
family physician tended to have fewer follow-up tests ordered for them and fewer 
referrals to other providers. 
 Little et al. (2001b) explored the impact of patients’ perceptions of patient-
centeredness on their experiences of enablement, satisfaction, and reduction of symptom 
burden in primary care consultations.  They found that patient-centered practices led to a 
greater sense of enablement, satisfaction, and reduction of symptom burden.  Use of 
patient-centered practices was also associated with a lower rate of referrals. 
Mead and Bower (2002) reviewed the literature on patient-centered 
communication in primary care consultations and patient satisfaction outcomes.  They 
found eight studies which evaluated the patient-centeredness of primary care physicians’ 
communications, and they concluded that the link between patient-centered 
communication styles and patient satisfaction was weak.  There did not appear to be 
much of a relationship between the degree of patient-centeredness in the physician’s 
consultation with the patient and the patient’s level of satisfaction with the visit. 
Mead, Bower and Hann (2002) conducted a study in which they used the Roter 
Interaction Analysis System to assess the degree of patient-centeredness of 173 
videotaped general practitioner consultations.  The Roter Interaction Analysis System is a 
coding scheme for analyzing the empathy and responsiveness in physicians’ 
communications to patients.  They sought to discover whether there was an association 
between a patient-centered consulting style and patient satisfaction and enablement.  
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They found that patient-centered behaviors on the part of the physician did not predict 
satisfaction or patient enablement. 
Patient-centered communication with breast cancer survivors was studied by 
Mallinger, Griggs & Shields (2004).  They examined breast cancer survivors’ experience 
with information and education provided by their oncologists, and they found that 
patients’ perceptions of patient-centered behavior were strongly associated with 
satisfaction with information provided, both about treatment and about cancer 
survivorship. 
Ciechanowski and Katon (2006) undertook a qualitative exploration of the 
patient-provider relationship in diabetes care.  In their study, patients with fearful 
attachment styles reported that providers’ patient-centered behaviors helped them to trust 
the care process more and to participate more fully in the patient-provider encounter. 
The Massachusetts Ambulatory Care Experiences Survey (Safran et al., 2006) 
sought to examine the contribution of several provider behaviors and organizational 
features during primary care encounters to perceptions of patient-centered care.  They 
found that organizational access and care integration were organizational characteristics 
associated with patient-centered care.  In addition, provider behaviors such as help 
making health behavior changes and communicating trustworthiness were associated 
with a perception of patient-centeredness. 
Zandbelt et al. (2007) examined the importance of patient-centered 
communication by internal medicine physicians.  They found that physicians’ patient-
centered communication was associated with patients’ active participation in the health 
care encounter.  Surprisingly, they found that physicians’ inhibiting behavior, which was 
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considered not to be patient-centered, was also positively associated with patients’ active 
participation in the visit.  They hypothesized that inhibiting behavior was the physicians’ 
response to patients’ increased participation in the visit. 
Patient-centered care principles have been associated with a recovery orientation 
in the rehabilitation of patients with severe physical disabilities (Stineman, Kurz, 
Kelleher & Kennedy, 2008).  Stineman et al. (2008) used a technique called Recovery 
Preference Exploration to determine the relative significance of a variety of functional 
activities to people with severe disabilities.  RPE enabled the participants to specify 
which activities were most important to them in their rehabilitation.  Stineman et al. 
concluded that RPE was a patient-centered method for conducting treatment planning and 
assessment with people in rehabilitation settings. 
In a study of patient-centered nursing practices on a bariatric unit, Wolf et al. 
(2008) found no differences in any of the health outcomes measured between patients in 
the intervention group and patients in the control group.  All patients had good health 
outcomes on measures such as post-operative complications, falls, or nosocomial 
infections.   Provision of patient-centered nursing care also did not create significant 
differences in patients’ perceptions of quality of care or patients’ reports of satisfaction 
with care received.  The authors noted that this may have been because the study was 
conducted in a Bariatric Center of Excellence, and the quality of care in the control group 
was most likely quite high as a result. 
Radwin, Cabral & Wilkes (2009) explored the relationship of several patient-
centered nursing interventions—individualization of care, responsiveness, proficiency, 
and care coordination—with outcomes for cancer patients.  They found that 
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individualization of care was associated with three desired health outcomes:  authentic 
self-representation, optimism, and sense of well-being.  The patient-centered nursing 
interventions of responsiveness and proficiency were related to subsequent trust in 
nurses. 
Empirical Research Using Patient-Centered Care:  Conclusions 
 The empirical research on patient-centered care indicates that there is a 
connection between patient satisfaction and patient-centered care practices.  The link 
between patient-centered care and positive health outcomes has been less strongly 
established.  Patient-centered care appears strongly related to empathetic communication 
between providers and patients.  In addition, patients seem to value and prefer patient-
centered approaches to communication, treatment planning, and care provision, even 
when strong links to better outcomes cannot be made.  This provides one substantial 
argument for continued use and study of patient-centered care practices in both direct 
care and programs/policies. 
 The current observations from research support continued refinement of the 
concept of patient-centered care as it is used in health services research.  They also 
indicate that approaches to health care that focus on patients’ needs and preferences may 
have value in ways that cannot yet be adequately measured.  Further research using 
patient-centered care as a dependent and as an independent variable may reveal new ways 
to assess patient-centered care and its impact on health care processes and outcomes.  In 
examining health care policy such as Medicare Part D, the lessons contributed by the 
existing studies emphasize the importance of communication to patient satisfaction, as 
well as the role of patient choice in perceptions of empowerment.  However, there 
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continues to be a need to establish stronger links between patient-centered care practices 
and positive outcomes. 
Patient-Centered Care as an Evaluation Framework 
 Despite the somewhat tenuous relationship between patient-centered care 
practices and better health care outcomes, patient-centered care is increasingly being used 
as a framework for the evaluation of health care services.  The constructs comprising 
patient-centered care have been used extensively as a way to evaluate aspects of clinical 
interventions, such as patient-provider communication, physical comfort of patients, and 
coordination of clinical services (Picker Institute, 2008).  As discussed above, patient-
centered care is also commonly used to describe aspects of direct care that emphasize 
patient empowerment and involvement in decision-making, as well as providers’ efforts 
to honor patients’ needs, values, and preferences.   
Some recent research suggests that adherence to patient-centered care principles, 
on both the clinical and system levels, can improve care efficiency and reduce inequities 
(Radwin et al., 2009; Little et al., 2001b).  Patient-centered care has also been associated 
with higher levels of satisfaction and patient trust (Ciechanowski & Katon, 2006; 
Zandbelt et al., 2007).  The Agency on Healthcare Research and Quality, in their 2009 
report on health care quality, connected the use of patient-centered care with a variety of 
positive health outcomes, particularly reduction in symptoms of illness (AHRQ, 2009).  
Delbanco (1995) has also described the ethical responsibility of providers to listen to 
patients and consider their concerns foremost.  In a line of reasoning similar to 
Delbanco’s assertion, Schauer et al. (2007) have stressed the importance of client-
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centered approaches to the values systems of health care providers and have emphasized 
the need to evaluate services on the basis of client-centered care principles. 
The Picker Institute (2008) has pioneered the use of patient surveys in health care 
settings that not only assess patient satisfaction with services, but also measure the 
occurrence of certain health care practices that embody patient-centered care.  The Picker 
Institute has stressed the importance of measuring specific practice behaviors rather than 
simply asking patients whether they are satisfied.  Global satisfaction surveys frequently 
report highly positive results; however, when patients are asked whether their health care 
providers helped them in certain ways, the results are quite different (Picker Institute, 
2010).   
The Institute of Medicine, in its report, Crossing the Quality Chasm, identified 
patient-centered care as an important criterion for evaluating health care (IOM, 2001).  
The 2001 IOM report includes patient-centeredness as one of its “six aims for 
improvement” in the health care system (IOM, 2001, p. 41).  The IOM report places an 
especially strong emphasis on individual choice and decision-making as a part of patient-
centeredness.  In addition, the importance of tailoring care to meet the needs of the 
patient, rather than the preferences of the provider, is stressed.  The IOM emphasized 
patient-centeredness not only in its 2001 Quality Chasm report, but also in its 2006 report 
on quality in substance use and mental health care (IOM, 2006). 
The International Alliance of Patients’ Organizations has embraced the adoption 
of patient-centered health care as one of its goals (IAPO, 2008).  IAPO emphasizes the 
importance of collaboration between patients and health care providers at all levels.  
IAPO is a coalition of health care consumer organizations from around the world, 
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representing many different conditions, such as cancer, diabetes, epilepsy, and other 
serious health diagnoses.  IAPO has promoted the adoption of patient-centered care 
principles, including patient involvement in the formulation of health care policy, as a 
way to evaluate the success of the health care system (IAPO, 2007).   
The Agency for Healthcare Research and Quality (AHRQ) has used patient-
centered care for the past five years in its report on the quality of U.S. health care 
(AHRQ, 2005-2009).  AHRQ has adopted patient-centered care as one of its leading 
indicators of health care quality.  Patient-centered care has assumed enough importance 
in the AHRQ’s definition of quality that patient-centered care data has been given its own 
chapter in the National Health Care Quality Report for the past several years (AHRQ, 
2006-2009).  According to the AHRQ, patient-centered care encompasses a variety of 
characteristics.  One of these is patients’ experience of care, which primarily centers on 
the patient’s ability to communicate effectively with the provider.  AHRQ also evaluates 
care coordination, integration of information, and continuity of care transitions as 
components of its patient-centered care definition (AHRQ, 2009). 
Broadening Our Concept of Patient-Centered Care:  The Patient-Centered 
Program 
The idea of patient-centered care has been used mostly as a measure of clinical 
care.  Some of the aspects of patient-centered care, as described by Gerteis et al. (1993) 
and as described by some other patient-centered care definitions, are particularly focused 
on transactions between the health care provider and the patient.  These include 
emotional support and physical comfort, for example.  However, there are a number of 
attributes of patient-centered care that can be used to evaluate health care programs and 
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systems.  Some of the definitions of patient-centered care described in Table 2.1 are 
especially concerned with the application of patient-centered care to health care 
programs, such as Shaller (2007) and Saha et al. (2008).  Many of the conceptualizations 
of patient-centered care include ideas that are applicable to health care programs.  Some 
of these ideas are as follows: 
• Accessibility.  As a clinical attribute, accessibility largely concerns being able to 
see a provider at the time and place that are most convenient to the patient.  As a 
program attribute, accessibility can include affordability of care, as well as access 
to customer service in a timely manner (Gerteis et al., 1993; Berry et al., 2003; 
Shaller, 2007). 
• Care coordination.  Individual providers play a role in coordinating care, but care 
coordination can also be supported by efficient structuring of health care 
programs to support communication between providers and smooth “hand-offs” 
between services (Graham Center, 2007; Saha et al., 2008). 
• Involvement of the patient.  This can include shared-decision making in clinical 
situations, and it can also include the provision of a variety of care options and 
control given to the patient to make the choice among those options.  It can also 
mean that patients have a meaningful role in policy-making (Mead &  Bower, 
2000; Bergeson & Dean, 2006; Radwin et al., 2009). 
• Information and education.  In addition to provision of information to patients 
about treatment options, information and education can include provision of 
information about how health care systems and programs work, so that patients 
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can use those programs most effectively and efficiently (Bechel et al., 2000; IOM, 
2001). 
• Secure transitions.  As with coordination of care, secure transitions can involve 
“micro”-level clinical transitions, as well as structuring health care systems so that 
patients can move seamlessly from one program to another (Gerteis et al., 1993; 
Berry et al., 2003). 
The concept of patient-centered care has changed expectations in a number of 
health care professions regarding the way that providers should communicate with 
patients about their care.  This has led to more meaningful informed consent, greater trust 
and comfort on the part of patients, and more open communication between providers 
and patients (Schauer et al., 2007; Ciechanowski & Katon, 2006).  The principles of 
patient-centered care can also be applied on a broader scale, to make the provision of 
health care in particular programs and systems more humane and centered on the needs 
and values of the patient.  Even in a large bureaucracy like the Medicare program, 
principles of patient-centered care can aid our understanding of how this system can be 
improved for the benefit of patients. 
Application of Patient-Centered Care to the Medicare Program 
 Prior research on the Medicare program has examined some of the characteristics 
of patient-centered policy as they apply to the Medicare benefit.  Researchers have 
examined the decision-making of Medicare beneficiaries as they use their values and 
preferences to choose specific plans.  In addition, the role of Medicare patient 
informational and educational materials has been examined.  The Access to Benefits 
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Coalition (ABC) has examined the impact of “person-centered outreach” approaches 
specifically related to Part D enrollment (ABC, 2006). 
One application of the notion of patient-centered care to the Medicare program 
can be seen in research concerning the decision-making process of health insurance 
consumers when it comes to selecting health plans.  Much of this literature emphasizes 
the importance of cost in beneficiaries’ choice of plans (Scanlon, Chernew, & Lave, 
1997).  However, there is some evidence to suggest that beneficiaries of public health 
insurance programs such as Medicare and Medicaid have somewhat different priorities 
than those who are privately insured.  In particular, Medicare and Medicaid beneficiaries 
are quite concerned with access and convenience associated with their health plans—
factors such as geographical location of plan providers and having a wide choice of plan 
providers matter much more to Medicare and Medicaid beneficiaries than they do to 
those who hold private insurance policies (Farley Short et al., 2002).  In addition, other 
research suggests that in a health care environment dominated by managed care 
strategies, non-cost factors will become increasingly important in all consumers’ choices 
of health insurance products (Scanlon et al., 1997).  This suggests that patient-
centeredness is most likely a very relevant construct in Medicare beneficiaries’ 
prioritization of Part D plans.  Accessible information about plan choices and provider 
locations contributes to patient-centered policy. 
 Another aspect of Medicare policy in which concerns about patient-centeredness 
are very relevant is in the quality of information provided to Medicare beneficiaries.  
Harris-Kojetin et al. (2001) and McCormack et al. (2001) examined the impact of 
Medicare information materials, such as the Medicare and You booklet and the booklet 
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describing the Medicare version of the Consumer Assessment of Health Plans Survey 
(CAHPS), on elderly and disabled Medicare beneficiaries’ perceptions of the benefit.  
Both of these studies found that beneficiaries valued these materials, and McCormack et 
al. (2001) found that having these materials helped beneficiaries to feel more confident in 
their health plan choices.  These informational materials support patient-centeredness in 
the delivery of the Medicare program, although dually-eligible and disabled beneficiaries 
did report in some cases that they would have appreciated more information about how 
the Medicare and Medicaid programs coordinate benefits (Harris-Kojetin et al., 2001).   
 As mentioned above, the Access to Benefits Coalition has found that outreach 
programs seeking to enroll vulnerable beneficiaries in the Part D low-income subsidy 
programs are more efficient and effective when they take a “person-centered” approach.  
This includes collaborating with individuals and organizations that are trusted by the 
beneficiary, as well as providing one-on-one counseling regarding eligibility and 
providing access to enrollment in other needs-based programs for which  the beneficiary 
may be eligible (ABC, 2006). 
Patient-centered care can be a useful conceptual framework for considering the 
impact of Medicare prescription drug policy.  Accessibility, information and education, 
and coordination of care are all relevant to Medicare policy in general, as well as to the 
operation of Medicare Part D. 
Goals of this Research 
This study will use the dimensions of patient-centered policy outlined above as a 
framework for evaluating the impact of the Medicare prescription drug benefit on the 
lives of an important subgroup of beneficiaries:  adults with serious mental illness.  
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Information from the Centers for Medicare and Medicaid Services, as well as the lived 
experiences of Medicare stakeholders, can provide a window into the workings of 
Medicare Part D “through the patient’s eyes” (Gerteis et al., 1993).  An assessment of the 
degree of patient-centeredness of the Medicare Part D program can contribute to our 
understanding of beneficiaries’ experiences with the program and provide direction to 
health care reform efforts based on that understanding. 
It is important to explore the extent to which the Medicare program is patient-
centered because the Medicare program serves some very vulnerable beneficiaries:  
senior citizens and people with disabilities.  These beneficiaries may not be as well-
connected in the community as non-disabled adults, so it may be harder for them to get 
what they need from their health care benefits.  Also, seniors and people with disabilities 
are likely to have a number of medical and mental health co-morbidities which makes it 
particularly important for them to be able to get the drugs they need.  They are more 
likely to have chronic concerns for which ongoing pharmaceutical treatments are 
especially important.  Psychiatric issues, in particular, may require careful medical 
follow-up and attention to the appropriate pharmaceutical treatment, as Huskamp et al. 
(2007) state that psychotropic medications are not as “therapeutically interchangeable” as 
medicines for other conditions (p. 308). 
Donohue (2006) points out that “The extent to which Medicare beneficiaries benefit 
from the new drug benefit will depend on the previous sources of coverage, level of drug 
spending, and specific characteristics of the plan they choose” (p. 717).  This study will 
examine the important “specific characteristics” of these plans and their contribution to 
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patient-centeredness, and it will explore their priority among adults with mental illness 
and their case managers. 
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CHAPTER III:  OVERVIEW OF RESEARCH DESIGN AND METHODS 
Introduction 
 This chapter provides a detailed description of the design and procedures used in 
this study.  The conceptual framework of patient-centered care and its application to 
health care programs is reviewed.  The overall study design and rationale are outlined.  
Qualitative methods are described, including topics to be considered in data collection, as 
well as procedures to be followed.  The methods used for collecting and evaluating plan 
comparison data are provided, along with a description of the procedure for integrating 
and triangulating qualitative and plan comparison information.  The chapter concludes 
with a summary of the research questions. 
Conceptual Framework:  Patient-Centered Programs 
 There are five main principles of patient-centered care that can be used on a more 
“macro” level—that apply to health care programs.  As reviewed earlier, they are 
accessibility, care coordination, involvement of the patient, information and education, 
and secure transitions.  These principles can be used in both qualitative explorations of 
stakeholders’ experiences as well as examination of plan performance data.  These 
principles of patient-centered care form a useful framework for the evaluation of health 
care programs such as Medicare Part D because they provide insight into patients’ 
perspectives on the functioning of the program. 
Design 
This study sought to determine not only whether Medicare stakeholders were 
satisfied with the Part D program, but also reasons why they were or were not satisfied.  
In order to accomplish this goal, methodological triangulation was employed (Speziale & 
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Carpenter, 2007).    Methodological triangulation involves using more than one research 
methodology to explore a particular question; for example, employing both a qualitative 
research approach and a quantitative approach (Bernard, 2002).  The purpose of 
triangulation is to increase the validity and reliability of study findings.  It is thought that 
if qualitative and quantitative methods yield similar answers to a research question, the 
results are more trustworthy (Bernard, 2002). 
First, the lived experiences of Medicare stakeholders were explored using focus 
groups and key informant interviews.  Data about stakeholders’ perceptions of the 
Medicare prescription drug benefit were gathered, allowing beneficiaries and their 
community helpers to speak for themselves.  The methodology of phenomenological 
analysis was used to collect the focus group and interview data (Padgett, 2008).  
Phenomenological analysis emphasizes learning through direct observation and the 
description of reality through words rather than numbers (Bernard, 2002).  The researcher 
is trying to see reality “through another person’s eyes” (Bernard, 2002, p. 23).  This 
approach was used in an attempt to understand stakeholders’ experiences with and 
feelings about Medicare Part D.  It also fits well with the patient-centered conceptual 
framework of the study, in which health care is examined “through the patient’s eyes” 
(Gerteis et al., 1993). 
In addition to the qualitative component of this study, plan comparison data from 
www.medicare.gov and the Centers for Medicare and Medicaid Services were examined 
to compare the degree of patient-centeredness of the various low-income-subsidy-
covered (also known as “benchmark”) plans available in the St. Louis, Missouri area.  
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The findings from different data sources and methods serve to reinforce one another and 
give confidence to the study results (Speziale & Carpenter, 2007). 
Following the collection of these data, the experiences of Medicare stakeholders 
were analyzed according to their relevance to various principles of patient-centered care.  
The perspectives of beneficiaries and community helpers were examined to see which 
aspects of patient-centered care were most important in their assessment of the Medicare 
program, and to evaluate how well the Medicare prescription drug benefit met 
expectations of a patient-centered program.  The approach of content analysis—
examining focus group transcripts to detect the presence of certain salient themes and 
ideas—was used to analyze these results (Bernard, 2002). 
Plan comparison data were triangulated with the qualitative data.  The principles 
of patient-centeredness identified as most critical in the qualitative inquiry were used to 
evaluate performance data on the six benchmark plans.  Plan comparison data were used 
to affirm the lived experiences of Medicare stakeholders (Padgett, 2008), to see whether 
benchmark Part D plans possessed the characteristics of patient-centeredness that 
stakeholders viewed as most important. 
The conceptual framework of patient-centered care (Gerteis et al., 1993) was used 
to guide the analysis, but the exploration of the data was not limited to patient-centered 
care concepts.  A content analysis approach was used, in that the investigator explored 
presence of themes related to patient-centered care; however, codes were not imposed 
upon the data prior to analysis.  The investigator attempted to allow the data to speak for 
themselves in the collection, coding, and analysis processes (Speziale & Carpenter, 
2007).  The investigator familiarized herself with principles of patient-centered care prior 
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to data coding, but during the process of data coding and analysis, she let the voices of 
the stakeholders guide her. 
Qualitative Methodology 
  In this study, focus groups and key informant interviews were used to obtain 
qualitative data from participants.  Focus groups are facilitated group discussions, 
generally consisting of between four and ten participants.  The facilitator asks questions 
of the group dealing with a focal topic, and discussion of the topic among group members 
is encouraged (Bernard, 2002).  Focus groups were chosen as the main method of data 
gathering because the investigator wished not only to discover stakeholders’ opinions 
about the Medicare prescription drug program, but also to understand the reasons why 
they held those opinions.  The methodology of focus groups allowed stakeholders to talk 
with one another about their perspectives. 
  Key informant interviews were also used with two Medicare beneficiaries.  These 
beneficiaries were seen as articulate, well-informed individuals with well-thought-out 
opinions on the Medicare Part D program (Bernard, 2002).  They were not available to 
participate during the scheduled focus groups, but they volunteered their perspectives, so 
the investigator chose to interview them separately and include their contributions in the 
qualitative data that were gathered. 
  Qualitative methods have not been used often to examine the Medicare Part D 
program.  Two focus group studies of the Part D program have been conducted in the 
past six years.  The first, conducted by researchers affiliated with the Kaiser Family 
Foundation (Perry, Kitchman, & Guyer, 2005), was not a study of the Part D program 
itself, but rather explored the opinions and perspectives of dually-eligible Medicare 
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beneficiaries regarding the impending implementation of the Medicare prescription drug 
program.  In this study, one focus group was conducted specifically with dually-eligible 
beneficiaries who had mental health-related disabilities.  The other focus group study of 
Medicare Part D was a study of access-related issues related to Part D conducted for the 
Medicare Patient Advisory Commission by researchers at University of Chicago and 
Georgetown University (Hargrave et al., 2008).  This study included focus groups with 
beneficiaries, physicians, and pharmacists. 
 The Kaiser Family Foundation has sponsored two projects conducting qualitative 
interviews of Part D stakeholders.  The “Voices of Beneficiaries” project (Kaiser Family 
Foundation, 2005; Kaiser Family Foundation, 2006; Perry, Dulio & Cubanski, 2006; 
Dulio, Perry & Cubanski, 2007) interviewed several dozen Part D beneficiaries, ten of 
whom were dually-eligible for Medicare and Medicaid, about their opinions and 
experiences related to Part D.  They interviewed beneficiaries in Lincoln, Nebraska; 
Baltimore, Maryland; Sacramento, California; and Miami, Florida and produced four 
qualitative reports detailing the responses of the interview participants.   These interviews 
were mostly conducted by telephone, though some were in person.  The Kaiser 
Commission on Medicaid and the Uninsured (Buchsbaum et al., 2007) also sponsored an 
interview study of “key informants”:  health care and social service providers as well as 
community leaders who had experience in working with dually-eligible beneficiaries. 
  A qualitative approach is particularly useful in examining the Medicare prescription 
drug benefit because it goes beyond the story told by pharmacy claims data and 
beneficiary surveys to explore experiences and opinions of stakeholders.  The objective 
pursued in the qualitative component of this study was to give voice to stakeholders—
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particularly those with mental illness and their helpers—regarding their perceptions of 
Medicare Part D. 
Sampling Strategy 
As mentioned above, the qualitative component of this study consisted of a series 
of focus groups and key informant interviews conducted with Medicare Part D 
stakeholders.  The purpose of the qualitative component was to obtain in-depth narrative 
information about stakeholders’ perceptions of the degree of patient-centeredness in the 
Part D program.  Focus groups were used in order to obtain the opinions of a range of 
people, to understand the factors that influence these opinions, and to generate new ideas 
(Krueger & Casey, 2000).  Key informant interviews were used to gather information 
from stakeholders who had difficulty making time to attend a focus group.  The focus 
groups and interviews were used to generate new ideas related to the application of 
patient-centered care principles to health care policies.  The value of focus groups in 
eliciting viewpoints of health care stakeholders, and in reducing the distance between 
consumers and policy-makers, has been discussed by Delbanco et al. (2001).  Rauktis, 
Feidler, and Wood (1998) have discussed the role that focus groups can play in 
evaluation of programs for people with mental illness.  They discuss the fact that focus 
groups can be helpful in obtaining information about reasons why consumers are satisfied 
with particular programs (Rauktis et al., 1998).  Though focus groups are often used in 
marketing and business settings, they have been increasingly utilized in social research 
on a variety of topics (Bernard, 2002). 
Mental health agencies from which participants were recruited were selected 
because they provided in-depth case management services to a population of adults with 
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serious mental illness.  These agencies also serve a large number of adults with low 
incomes, who use both Medicare and Medicaid to obtain their health care.  This led to the 
ability to conduct an intensive exploration of the phenomenon of Medicare Part D 
utilization (Ulin, Robinson, & Tolley, 2005). 
To learn the perspectives of Medicare beneficiaries with mental illness, six focus 
groups and two key informant interviews were conducted at three community-based 
mental health agencies.  Two focus groups and one key informant interview were 
conducted at Agency A, a non-profit agency in the City of St. Louis that provides 
housing, psychosocial rehabilitation, integrated dual-disorders treatment, and assertive 
community treatment to adults with severe mental illness.  One focus group and the 
interview were conducted at the Agency A club house.  The other Agency A focus group 
was conducted at an assisted-living facility operated by the agency.  Two focus groups 
were held at the headquarters of Agency B, a non-profit agency in the City of St. Louis 
that provides case management, integrated mental health and chemical dependency 
treatment, and assertive community treatment.  Two focus groups and one key informant 
interview were held at Agency C, a non-profit agency in the City of St. Louis that 
provides supported employment services, psychosocial rehabilitation, and case 
management, as well as other mental health services.  The groups and interview at 
Agency C were held at the agency’s main headquarters, which houses the agency’s club 
house program.   
Community support workers’ and nurses’ perspectives were also important to this 
project.  Community support workers and nurses were recruited through Agency A and 
Agency C.  One focus group was held at Agency C, and two were held at Agency A.  
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One community support worker focus group was held at Agency C’s headquarters.  One 
community support worker-nurse case manager group was held at Agency A’s assisted-
living facility.  The other community support worker focus group was held at the 
headquarters of Agency A.   
Inclusion Criteria 
Qualitative data were gathered from two different groups of Medicare 
stakeholders.  Stratified sampling was used to conduct focus groups of Medicare 
beneficiaries with mental illness and of community support workers who serve adults 
with mental illness. 
 First and foremost, it was important to obtain information about beneficiaries’ 
experiences with the prescription drug benefit.  Individuals with mental illness were 
recruited for these groups by word-of-mouth and through flyers posted at the agencies.  
In addition, at Agency A and Agency C, the investigator gave brief research presentations 
to clubhouse members to provide information about the study and encourage clubhouse 
participants to sign up for the groups. 
Community support workers and nurse-case managers also play an important role 
in assisting individuals with mental illness to use Part D (Mishler, 2009).  Community 
support workers and nurses were recruited for focus groups via word-of-mouth and 
through informational flyers distributed at the agencies.  At Agency A, two team leaders 
volunteered their community support teams to participate in groups.  At Agency C, 
community support workers and team leaders responded to information made available at 
the agency.  Although groups were open to both community support workers and to 
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nurse-case managers, the groups are referred to as community support worker (CSW) 
focus groups, as only one nurse-case manager participated. 
 Inclusion criteria for each stakeholder group. 
To participate in the study, Medicare beneficiaries needed to be clients of the 
participating agencies.  In addition, they were required to be their own legal guardians, 
and they had to be beneficiaries of both the Medicare and Medicaid programs.  A brief 
assessment of each Medicare beneficiary’s cognitive capacity to complete the interview 
was conducted before the focus groups began. 
Community support workers and nurse-case managers had to be employed by the 
agency hosting the focus group in order to participate.  They were also required to be 
engaged in a direct practice capacity with adults with mental illness. 
Data Collection 
 Protection of human subjects. 
All study procedures related to collection of the qualitative data were reviewed 
and approved by the Washington University Human Research Protection Office.  The 
Institutional Review Board of Agency A also approved the study procedures.  The 
clinical directors at Agency B and Agency C gave approval for collection of qualitative 
data at their agencies.  The Washington University Human Research Protection Office 
waived written consent for this study because the written consent form would have been 
the only document identifying participants by name.  Verbal consent was obtained from 
all participants at the time that demographic information was collected.  In addition, the 
investigator conducted a brief assessment of each participant’s cognitive capacity prior to 
the start of each focus group and interview.  A study information sheet was provided to 
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each participant outlining the kinds of information that would have been in a consent 
form, and the requirements of study participants were explained to all group members 
and interviewees.  Refreshments (cereal bars, granola bars, and cookies) were served to 
focus group and interview participants.  All focus group and interview participants were 
offered a $10 gift card to a local grocery store to thank them for their participation. 
The digital voice recorder containing focus group and interview recordings, hard 
copies of study transcripts, and demographic data sheets were stored in a locked file 
cabinet in a locked office at the George Warren Brown School of Social Work. 
Focus groups and interviews. 
Focus groups and interviews were held in a variety of settings at the participating 
agencies.  At Agency C, the focus groups and the interview were held in conference 
rooms at the agency headquarters.  At Agency A’s assisted-living facility, focus groups 
were held in the group home office and in the living room of the group home.  At Agency 
A’s headquarters, the consumer focus group was held in a conference room, the 
consumer interview was held in the clubhouse, and the CSW focus group was held in the 
community support team office.  At Agency B, both consumer focus groups were held in 
an agency conference room.  Due to resource constraints, the investigator conducted all 
focus groups and interviews by herself.   
Demographic information on race/ethnicity, gender, educational level, and zip 
code of residence was collected.  Twenty-nine of the 31 consumer participants provided 
all demographic data requested.   All fifteen of the CSW/nurse case manager participants 
provided all demographic data requested. 
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Focus group questions addressed stakeholders’ perceptions of various attributes of 
Part D plans, particularly those attributes which are relevant to the Picker Institute 
definition of patient-centered care.  Examples of focus group questions that were used 
include the following. 
Table 3.1.  Focus Group Questions by Stakeholder Group 
 
 Consumer Community Support Worker/Nurse 
Case Manager 
Transition from 
Medicaid to 
Medicare Part D 
How did your health care 
change when you switched 
from Medicaid drug 
coverage to Medicare? 
How did your work with clients 
change when dually-eligible clients 
were switched from Medicaid to 
Medicare Part D? 
Respect for 
patients’ needs 
How well does your 
Medicare prescription drug 
insurance meet your needs 
for prescription medicine? 
How well is the Medicare Part D 
program meeting the medication 
needs of your clients? 
Availability of 
choices 
How would you describe 
your prescription drug 
insurance in terms of the 
choices it offers you? 
 
Comprehensiveness 
of coverage 
How would you describe 
your prescription drug 
insurance in terms of the 
coverage that it offers? 
(Probes:  for example, how 
are the copayments?  How 
are the premiums?) 
How comprehensive is the 
Medicare Part D benefit in covering 
the medications needed by your 
clients? 
Sources of 
information 
What is your main source 
of information about your 
prescription drug 
insurance? 
What is your main source of 
information about Medicare? 
Communication 
with beneficiaries 
How does your prescription 
drug insurance plan 
communicate with you?  
(Probes:  do you receive 
written communication, 
telephone calls, e-mails?) 
How could Medicare Part D plans 
communicate more effectively with 
their beneficiaries? 
Coordination of 
benefits 
 How well-coordinated is Medicare 
Part D with other health care 
programs?  (such as Medicare A 
and B; Medicaid) 
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Services and 
supports provided 
to beneficiaries 
What kind of help have you 
received in using your 
prescription drug 
insurance? 
What kind of help do you provide 
to your clients in using their 
Medicare Part D benefits? 
Becoming more 
patient-centered 
How could the Medicare 
prescription drug program 
be more patient-centered? 
How would Medicare drug 
coverage change if it 
became more patient-
centered? 
How could the Medicare 
prescription drug program be more 
patient-centered? 
How would Medicare drug 
coverage change if it became more 
patient-centered? 
 
 Focus groups ranged in length from 45 minutes to one hour; key informant 
interviews ran from 30 to 45 minutes.  The length of each group was somewhat shorter 
than the usual length for a focus group; this occurred for a number of reasons.  First of 
all, groups and interviews with consumers were kept somewhat shorter than usual to 
accommodate the energy levels and attention spans of participants with thought disorders 
(Rauktis et al., 1998).  Focus groups with CSWs were kept short because groups were 
held in conjunction with team staff meetings, and the amount of time that these case 
managers were willing to allot to a research project was limited.  It was determined that it 
was better to facilitate a short focus group than not to collect the data at all. 
 In the process of data collection, the investigator sought to obtain an “insider” 
point of view on Medicare (Padgett, 2008).  Questions were formulated to go inside of 
stakeholders’ experiences and understand the benefit from their viewpoint.  Patient-
centered care concepts were used as an organizing principle, but narratives of 
stakeholders’ experiences were sought in the focus groups and interviews.  The 
investigator was partially successful in achieving this “insider” perspective.  In several of 
the focus groups, participants “warmed up” to the investigator after several introductory 
questions and assurances of confidentiality.  Information shared in the groups tended to 
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become more detailed as the groups progressed.  Participants were encouraged to share 
detailed examples of their own experiences, and many chose to do so.  The investigator 
observed that she was able to gain a greater insider viewpoint when talking to community 
support workers, as these participants knew that the investigator had once worked in a 
community mental health setting in a position similar to their own.  Community support 
workers appeared eager to share “war stories” about the Medicare prescription drug 
benefit, whereas beneficiaries for the most part expressed few complaints. 
Data Entry and Management 
 Interviews and focus groups were recorded using a small digital voice recorder.  
The digital voice recorder was stored in a locked file cabinet in a locked office at the 
George Warren Brown School of Social Work.  The investigator transcribed all 
interviews and focus groups verbatim.  Following the transcription of interviews and 
focus groups, all transcripts were entered into the NVivo data management program 
(QSR International, 2009).  Transcripts were coded using a strategy of phenomenological 
analysis (Padgett, 2008).  Sorrell and Redmond (1995) have discussed the use of small 
group interviews to obtain “pictures” of the lived experiences of participants (p. 1120).  
Consumer and CSW transcripts were coded separately to allow each stakeholder group to 
speak for itself.  Recurrent, salient, words and ideas were identified throughout the 
transcripts and coded and sorted accordingly (Morse & Field, 1995).  Codes were then 
grouped into major themes for each stakeholder group. 
Collection of Plan Comparison Data 
The sources of data for comparison of the six benchmark Part D plans were the 
www.medicare.gov Web site and the Part D performance report card data from the 
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Centers for Medicare and Medicaid Services.  The www.medicare.gov Web site has been 
used in previous research on Medicare Part D formularies; Tseng et al. (2007) used 
www.medicare.gov to obtain information about drug coverage variation among Part D 
plans.  They used the information obtained from the Web site to evaluate the proportion 
of Part D plans in California and Hawaii that covered certain commonly-prescribed 
medications.  They noted that abstracting these data from the Medicare Web site took a 
considerable amount of effort but made no comments about advantages or disadvantages 
of using the prescription drug plan finder.  Davis et al. (2007) also used the Formulary 
Finder to obtain information about coverage of medications by different Part D plans; 
they used the information to compare the generosity of Part D coverage among various 
states.  Domino et al. (2008) used the Formulary Finder on the Medicare Web site to 
estimate changes in prescription drug costs for non-dually-eligible beneficiaries over the 
course of a typical year.  They also made mention of the fact that using the Formulary 
Finder to abstract data about plan coverage was time-consuming.  Joyce et al. (2009) used 
the www.medicare.gov Web site to abstract information about formularies and out-of-
pocket spending for beneficiaries after their first two years in the program. 
Researchers from the Kaiser Family Foundation have also used the prescription 
drug plan finder on the Medicare Web site to obtain information on covered medications 
and the use of utilization management tools in the formulary coverage of Part D plans 
(Hoadley, Hargrave, Cubanski & Neuman, 2008).   
Data were abstracted from the Medicare Web site by entering the names of 
prescription medicines into the Formulary Finder and obtaining information about the 
coverage and use of utilization management by each benchmark plan.  This was an 
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important exercise not only because it provided data about each plan’s formulary, but 
also because it approximated the process that the Centers for Medicare and Medicaid 
Services expects Medicare Part D beneficiaries to go through each year when they are 
choosing a Part D plan.  As noted by several of the other researchers who have used the 
Formulary Finder to inform their studies, it is a time-consuming and cumbersome 
process. 
The Part D performance data are publicly available in an Excel spreadsheet that 
can be downloaded from the CMS Web site.  The performance data are collected by CMS 
during their monitoring activities; they are not reported by Part D plans.  Plan ratings are 
released each fall by CMS (Lee-Martin, personal communication, 7/27/09).  This 
Medicare Part D “Report Card,” as it is called, has not been used in Part D published 
research.  It is used by the Centers for Medicare and Medicaid Services for their 
monitoring of Part D plans.  Plans that receive low ratings on the performance criteria 
may receive follow-up attention from CMS or be required by CMS to improve their 
ratings (Lee-Martin, personal communication, 7/27/09).  The published research studies 
on Medicare Part D tend to use pharmacy claims data (for example, Yin et al., 2008; and 
Lichtenberg & Sun, 2007) or to use other national surveys of Medicare beneficiaries, 
such as the Medicare Current Beneficiary Survey (Madden et al., 2008).  For the 
purposes of these studies, claims data and survey data are appropriate because the studies 
are examining characteristics of individual Part D beneficiaries and their utilization of 
prescription medications.  For this study, Medicare Part D performance data are 
appropriate because they contain information on beneficiary satisfaction with Part D 
plans, on the level of the Part D plans themselves.  The Part D performance data contain 
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up-to-date, accessible information on a variety of aspects of consumer satisfaction with 
Part D plans.  Since this study is evaluating plans, the performance data are at the right 
level of analysis. 
Formulary and utilization management information was abstracted from the 
www.medicare.gov Formulary Finder in August, 2009.  Plan comparison data from the 
Centers for Medicare and Medicaid Services Part D Performance Data were downloaded 
from the CMS Web site in July, 2009. 
Plan Comparison Data Sampling Strategy 
The six benchmark plans in the St. Louis, Missouri area whose premiums were 
fully-covered by the low-income subsidy in 2009 will be examined.  These are:  Aetna 
Medicare Rx Essentials, Community CCRx Basic, First Health Part D – Premier, 
HealthSpring Prescription Drug Plan – Reg 18, Medco Medicare Prescription Plan – 
Value, and Medicare Rx Rewards Standard.  These plans were identified using the 
www.medicare.gov Plan Finder. 
  The State of Missouri will be used because Missouri has had a reasonably generous 
drug benefit under Medicaid, and because Missouri has a variety of low-income-subsidy-
eligible Part D plans from which beneficiaries can choose.  Missouri is also the site of 
this research because of the feasibility of collecting qualitative data on stakeholders in the 
St. Louis region. 
Variables 
  Data on the various Part D plans were obtained from the Centers for Medicare and 
Medicaid Services and the www.medicare.gov Web site.  The purpose of the quantitative 
analysis was to examine attributes of Medicare prescription drug plans that contribute to 
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patient-centeredness.  Plans were compared on five attributes to determine which plans 
were more or less patient-centered.  Each attribute corresponds with one of the identified 
dimensions of patient-centered care.  Attributes include formulary inclusiveness, 
implementation of utilization management tools, beneficiary perception of plan 
information, rate of plan complaints, and rate of complaints about plan switching.  A 
percentage or rate was calculated for each attribute of each plan.   
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Table 3.2.  Part D Plan Attributes 
 
Attribute Dimension of 
Patient-
Centeredness 
Attribute 
Definition 
Attribute Score Source of 
Information 
Formulary 
inclusiveness 
Respect for 
patients’ values, 
preferences, and 
expressed needs 
What percentage 
of the drugs in 
Huskamp et al.’s 
(2007) list of 
psychotropic 
medications does 
the formulary 
include? 
 
(15 
anticonvulsants; 19 
antidepressants; 12 
atypical 
antipsychotics) 
Percentage of 
medications 
included in the 
formulary 
www.medicare.gov 
Implementation of 
utilization 
management tools 
Access to care What percentage 
of the drugs in the 
Huskamp et al. list 
require the use of 
utilization 
management tools 
such as prior 
authorization, 
quantity limits, or 
step therapy to be 
covered by the 
plan? 
Percentage of 
medications that 
require utilization 
management tools 
www.medicare.gov 
Rate of complaints 
about the drug plan 
benefits and access 
to prescription 
medications 
Coordination and 
integration of care 
What is the rate of 
complaints about 
drug plan benefits 
and access to 
prescription 
medications that 
have been lodged 
with the Centers 
for Medicare and 
Medicaid  
Services? 
Rate of plan 
complaints per 
1,000 beneficiaries 
Centers for 
Medicare and 
Medicaid Services 
Drug plan’s ability 
to provide 
information or  
help when 
members need it 
Information, 
communication, 
and education 
What is the 
percentage of plan 
members who feel 
that the drug plan 
has provided them 
with the 
information and  
help they have 
needed? 
Percentage of plan 
members who 
report that their 
drug plan has 
provided them 
with information 
or help when they 
have needed it 
Centers for 
Medicare and 
Medicaid Services 
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Rate of complaints 
about plan 
switching 
Continuity and 
secure transitions 
What is the rate of 
complaints lodged 
with CMS about 
joining or leaving 
specific 
prescription drug 
plans? 
Rate of complaints 
per 1,000 
beneficiaries 
Centers for 
Medicare and 
Medicaid Services 
 
 
 For data on the plan formularies, each drug being considered was entered into the 
Formulary Finder on the www.medicare.gov Web site to determine whether it was included 
in the plan formulary.  The list of prescription drugs that was used was taken from the 
Huskamp et al. (2007) article in Psychiatric Services, in which the authors used a list of 
commonly-prescribed psychotropic medications to compare the inclusiveness of Part D 
formularies.  The Huskamp et al. list includes 15 anticonvulsants, 19 antidepressants, and 
12 atypical antipsychotics.  This list does not include several brand-name and generic 
medications that were approved by the Food and Drug Administration after the article was 
published.  For example, generic risperidone is now available in many Part D plans, but 
when the Huskamp et al. article was published, only brand-name Risperdal was available to 
consumers.  This may lead to percentages of drugs covered by plans that do not include 
medicines recently added or taken out of plan formularies.  Some plans routinely remove 
brand-name preparations from formularies once a generic is approved, so using a list that is 
two years old may mean that percentages of drugs covered seem unusually low.  Other 
plans may continue coverage of all preparations but use quantity limits or other utilization 
management tools more extensively with brand-name versions of drugs.   
   Even so, the Huskamp et al. list comprises a reasonably comprehensive list of 
psychotropic medications that are prescribed to individuals with chronic psychiatric 
disorders in three major categories:  anticonvulsants (used in mood disorders), 
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antidepressants, and atypical antipsychotics.  Although the rates of covered drugs and 
rates of drugs affected by utilization management may be slightly different as a result of 
new brand-name preparations and generics entering the market, the overall picture of 
drug coverage provided by use of the Huskamp et al. list is fairly realistic and includes 
almost all drugs commonly prescribed for persons with serious mental illness. 
   The use of this list also mirrors a real-life problem that many stakeholders face in 
using the formulary finder.  Though beneficiaries are restricted in the number of times 
that they can change plans, Medicare Part D plans can change their formularies whenever 
they choose.  Keeping up with the rapid pace of changes in plan formularies is difficult 
even for the savviest beneficiary.  Beneficiaries may not know which of their medications 
are available as generics or may not have the most up-to-date knowledge of new 
preparations.  This makes it difficult to keep track of the many changes in plan 
formularies that can happen within a short period of time.   
   The Formulary Finder on the Web also provided information on which drugs 
required utilization management tools such as prior authorization, step therapy, and 
quantity limits.  Each drug on the Huskamp et al. (2007) list was entered into the 
Formulary Finder, and the information provided about utilization management tools was 
recorded into a table.  The Formulary Finder provides information about prior 
authorization, step therapy, and quantity limits.  Prior authorization means that the 
beneficiary must receive special permission from their health care provider before he/she 
can have a prescription for that particular drug filled.  In step therapy, the beneficiary is 
required to try a lower-cost alternative medication first, and to show that he/she has failed 
to have a therapeutic response to that medication, before he/she is allowed to fill a 
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prescription for the more expensive medication.  A plan uses quantity limits when it 
requires a beneficiary to be limited to a certain quantity of the medication per month, 
such as 30 tablets per month for a medication that is taken once a day. 
   Two different rates of plan complaints were obtained from the Part D performance 
data made available by CMS.  The first was the rate of plan complaints about drug plan 
benefits and access to prescription medicines.  The other was the rate of complaints about 
joining or leaving different prescription drug plans.  Complaints about drug plan benefits 
and access to medicines provide information about the patient-centered care attribute of 
coordination and integration of care.  Complaints about joining and leaving prescription 
drug plans give insight into transition and continuity of care among plans.  The 
percentage of plan beneficiaries who believe they get the information or help they need 
from their plan has also been taken from the Part D performance data.  This helps to 
determine the plans’ adherence to the attribute of information and education for 
beneficiaries. 
Methodological Triangulation 
   The qualitative and plan comparison findings were obtained sequentially, and focus 
group and interview findings were triangulated with plan comparison information.  For 
example, qualitative findings related to satisfaction with Part D plans, experiences with 
formularies, and perception of information and communication from Part D plans were 
compared with the quantitative data related to these same concepts.  This approach was 
chosen to increase confidence in the results of each method.  When two different research 
methods, such as a qualitative and a quantitative approach, are used together and the 
results compared, and similar findings are uncovered, the validity of the findings 
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increases (Bernard, 2002).  The investigator examined the plan comparison data for 
aspects of patient-centered care that appeared most important to Medicare stakeholders.  
Performance of benchmark Part D plans was assessed using attributes of patient-centered 
care.  This helped the investigator to determine whether Part D plans were adhering to 
patient-centered care characteristics that mattered most to stakeholders.  In the 
interpretation of the data, findings were merged so that a unified outcome could be 
achieved (Speziale & Carpenter, 2007). 
Summary of Research Questions 
   Through collection of qualitative and plan comparison data, this study sought to 
answer three research questions. 
Research Question 1:  How do Part D stakeholders assess the patient-centeredness of the 
Medicare prescription drug benefit? 
Research Question 2:  What elements of patient-centered care are recognized by 
stakeholders as most critical to an effective prescription drug program? 
Research Question 3:  How do the “benchmark” plans in one Midwestern state perform on 
measures of patient-centeredness considered most crucial to stakeholders? 
   Focus groups and interviews were conducted to determine the attitudes and 
experiences of Medicare stakeholders regarding the Part D benefit.  The qualitative data 
collection also enabled the author to consider the elements of patient-centered care that 
stakeholders viewed as most important, and how these elements related to their 
experiences of the Part D program.  By examining plan comparison data, the author was 
able to take these patient-centered care attributes and apply them to the performance of 
the six benchmark Part D plans in Missouri in 2009.  Assessment of benchmark plans 
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relative to the most important patient-centered care attributes gave further insight into the 
adequacy of the Part D program in meeting the needs of beneficiaries with mental illness. 
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CHAPTER IV:  RESULTS 
Introduction 
 In this chapter, results of the qualitative data collection and the quantitative plan 
comparison data collection are described.  For the qualitative data, the results from the 
focus groups and key informant interviews serve to answer the first two research 
questions:  Research Question 1:  How do Part D stakeholders assess the patient-
centeredness of the Medicare prescription drug benefit? and Research Question 2:  What 
elements of patient-centered care are recognized by stakeholders as most critical to an 
effective prescription drug program?  These results are organized by first describing the 
sample, both mental health consumers and community support workers/case managers.  
Following this, the analytic process is described, and codes for both consumer and 
community support worker (CSW) data are outlined.  Major themes of consumer and 
CSW data are put forth, along with illustrative quotations from the qualitative data.   
Following the presentation of the qualitative findings, quantitative plan 
comparison data are discussed.  These data answer Research Question 3:  How do the 
“benchmark” plans in one Midwestern state perform on the measures of patient-
centeredness considered most crucial to stakeholders?  The sources of the plan 
comparison data are described, and the variables to be considered are outlined.  This is 
followed by a description of the questions answered by each variable explored. 
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Qualitative Data:  Sample Description 
Consumer Focus Groups 
 There were 29 participants in six consumer focus groups and two participants in 
key informant interviews that took place over a ten-week period in Fall, 2009.  The 
breakdown of participants in each focus group was as follows: 
Table 4.1  Focus Group and Interview Participants 
Group/Interview Participants 
Agency A Group #1 
9/15/09 
3 
Agency A 
Interview #1 
9/16/09 
1 
Agency A Group #2 
11/19/09 
10 
Agency  B Group #1 
9/9/09 
2 
Agency B Group #2 
9/16/09 
4 
Agency  C Group #1 
8/31/09 
2 
Agency C 
Interview #1 
9/3/09 
1 
Agency C Group #2 
9/8/09 
8 
 
Consumer Demographics 
Demographic characteristics were collected on consumer participants.  
Participants tended to be middle-aged and older; the youngest participant was 28 and the 
oldest was 74.  The mean age for consumer focus group/interview participants was 51.5.  
Seventeen (54.8%) of the consumer participants were female, and 14 (45.2%) were male.   
 All 31 consumer participants reported their race/ethnicity.  Nineteen participants 
(61.3%) were African American.  Eight participants (25.8%) were Caucasian; one (3.2%) 
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was Asian American.  Two (6.5%) reported their race/ethnicity as “American,” and one 
(3.2%) was American Indian. 
Table 4.2  Race/Ethnicity of Consumer Focus Group and Interview Participants 
Race/Ethnicity Number Percentage 
African American 19 61.3% 
Caucasian 8 25.8% 
Asian American 1 3.2% 
“American” 2 6.5% 
American Indian 1 3.2% 
Total 31 100% 
 
Twenty-nine participants reported their educational level.  Over half of the 
participants had a high school education or less; eight (27.6%) had less than a high school 
education, and eight (27.6%) were high school or GED graduates.  Ten participants had 
taken some college courses (34.5%), two (6.9%) were college graduates, and one (3.4%) 
had a master’s degree. 
Table 4.3  Educational Level of Consumer Focus Group and Interview Participants 
Educational Level Number Percentage 
Less than high school 8 27.6% 
High school/GED 8 27.6% 
Some college 10 34.5% 
College graduate 2 6.9% 
Master’s degree 1 3.4% 
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Missing 2 6.9% 
Total 31 100% 
 
 Twenty-nine consumer participants reported their zip code of residence.  
Consumer participants came from ten different zip code areas, mostly in St. Louis City.  
Three participants reported that they lived in St. Louis County.  Fourteen of the 
participants (49.3%) came from 63110 or 63108, which are zip code areas very close to 
the locations of the community mental health agencies where they were receiving 
services.  Both of these zip code areas contain high percentages of individuals living 
below the poverty line.  In zip code area 63110, 22.2% of residents are living below the 
poverty line, and 9.6% of residents are living below 50% of the poverty line (“63110 Zip 
Code Profile,” 2010).  In zip code area 63108, 29.4% of residents are living below the 
poverty line, and 14.2% of residents are living below 50% of the poverty line (“63108 
Zip Code Profile,” 2010).  This is in comparison to an overall poverty rate in the city of 
St. Louis of 24.6% in the year 2000 (City of St. Louis CDA, 2005).  These numbers are 
considerably higher than the averages for the entire state of Missouri, which has 13.4% of 
residents living in poverty and 5.5% of residents living below 50% of the poverty line 
(“63108 Zip Code Profile,” 2010). 
Community Support Worker Focus Groups 
Three focus groups were conducted with community support workers over a 
three-month period in 2009-2010.   Participants were as follows: 
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Table 4.4  Summary of CSW Focus Group Participants 
Group Participants 
Agency A Community Support Team 
1/16/10 
5 
Agency A Assisted Living Facility Team 
1/16/10 
4 
Agency C Community Support Workers 
10/28/09 
6 
 
One focus group was conducted at Agency C, with community support workers 
and team leaders.  One focus group was conducted at Agency A’s assisted-living facility, 
with a team leader, two community support workers, and one nurse-case manager.  The 
last focus group was held at Agency A, with a team leader and community support 
workers.   
Community Support Worker Demographics 
In terms of ethnicity, ten community support worker participants were Caucasian, 
three were African-American, one was Asian, and one, who had emigrated from 
Germany to the United States, identified herself as “German.”  Ten community support 
workers were female, and five were male.  The average age of community support 
workers was 39.5, with the oldest being 66 and the youngest being 26.  Six of the CSW 
participants reported their residence as being in the City of St. Louis, while nine reported 
living in suburban areas. 
Ten of the CSW participants had master’s degrees, and five had a college 
education.  Nine of the participants did not specify the discipline of their degree.  Three 
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stated that they had degrees in social work; two had graduate degrees in psychology; and 
one had a bachelor’s degree in nursing. 
Qualitative Results 
Focus group transcripts were analyzed using phenomenological analysis (Padgett, 
2008).  The goal was to identify themes that would provide insight into stakeholders’ 
experiences with the Medicare prescription drug program.  Denzin and Lincoln (2005) 
discuss the use of focus groups and other qualitative approaches in an applied manner, 
with the goal of informing public policy and professional practice.  The intent was to use 
the lived experiences of Medicare stakeholders to provide information about the 
operation of the Medicare prescription drug program in the lives of a very vulnerable 
group of beneficiaries.  The juxtaposition of a phenomenological approach with the use 
of patient-centered care themes has benefits and drawbacks.  Exploring the personal 
experiences of stakeholders provided rich, detailed knowledge of the workings of the 
Medicare benefit.  Using patient-centered care themes to structure these observations 
gave immediate practical relevance to the findings and aided in understanding the 
meaning of stakeholders’ experiences.  However, by using these constructs to shape 
observations regarding the data, other themes and experiences may not have been 
considered.  The investigator attempted throughout the data collection and analysis 
process to hear the voices of stakeholders as they discussed their perceptions of 
satisfaction and areas of concern related to Medicare Part D. 
A content analysis of the focus group data, looking for particularly relevant 
constructs and themes, was employed (Morse & Field, 1995).  Focus group and interview 
transcripts were entered into NVivo (QSR International. 2009) for coding and analysis.  
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The transcripts were examined line-by-line for recurring themes and important concepts 
related to the lived experience of Medicare stakeholders.  Community support worker and 
Medicare beneficiary focus groups were coded separately.  However, many codes 
revealed similar themes across stakeholder groups.    For Medicare consumer data, 
nineteen codes were identified.  They are as follows: 
Table 4.5  Consumer Data Codes 
Data Code 
Concerns about health care reform 
Co-payments okay 
Co-payments not okay 
Costs okay 
Costs not okay 
Dental insurance problems (this relates to a 
Medicaid cut; it does not relate directly to Medicare 
Part D but it is on the minds of many consumers) 
Formulary problems 
Generic drugs okay 
Generic drugs not okay 
Help from mental health agencies 
Help from pharmacists 
Information from Medicare helpful 
Information from Medicare not helpful 
Medicaid spend-down (again, not directly related to 
Medicare Part D but on the minds of many 
consumers) 
Not satisfied with Part D (General comments 
related to dissatisfaction with Part D) 
Satisfied with Part D 
Paperwork 
Problems with Medicare Advantage 
Problems with utilization management (in Part D 
plans) 
 
All codes related to consumers’ experience with Medicare prescription drug 
benefits, except for “dental insurance problems” and “Medicaid spend-down.”  Data 
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concerning these two codes were identified and coded because these two issues were on 
the minds of many Medicare consumers and in some cases affected consumers’ 
perceptions of the utility and affordability of the Medicare program. 
The analysis attempted to strike a balance between a search for themes that have 
already proven relevant in other studies of patient-centered care and Medicare and 
openness to new topics and ideas expressed by focus group participants.  The investigator 
accomplished this by reviewing the patient-centered care literature prior to coding the 
data, but allowing the coding process to be shaped by themes brought up by participants.  
Specific patient-centered care principles were mapped onto data codes after the coding 
process was completed, so that themes would not be limited to principles of patient-
centered care. 
 Data from the CSW focus group transcripts were coded and sorted in a process 
similar to that used for the consumer data.  There was no particular effort made to create 
codes that were similar to the consumer codes.  However, many of the codes share 
characteristics with consumer codes.  Fourteen codes were developed for the CSW data. 
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Table 4.6  Community Support Worker Data Codes 
CSW Data Code 
Action on Behalf of Consumer 
Communication with Members 
Costs Not Okay 
Costs Okay 
Dealing with Bureaucracy 
Health Care Reform 
Part D Okay 
Pharmacies Helpful 
Prescription Issues 
Problems with Medicare Advantage 
Problems with Physicians 
Problems with Switching Plans 
Stress for Consumers 
Utilization Management 
 
Consumer Results 
 Consumer data codes have been summarized below in six main categories that 
appear consistently throughout the coding.  Categories were chosen as significant based 
on the frequency with which that particular theme appeared in the transcripts.  Categories 
are as follows:  Overall satisfaction, affordability, paperwork, satisfaction with generic 
medications, interactions with pharmacists, and interactions with mental health agencies. 
 Overall satisfaction. 
 Overall satisfaction with the Medicare prescription drug benefit was high among 
beneficiaries.  Many interview participants stated, “I don’t have no problems with 
Medicare.”  For example, one participant stated, “So, uh, the Part D…I have (Part D 
plan) now, and I’m really satisfied with them.”  Another participant mentioned, “I don’t 
have no problems.  I’m very happy for me.”    Another beneficiary commented, “I guess 
I’m basically satisfied.  Because, I’m thinking it might be just the medication, I take 
medication for mental health, you know, depression, anxiety, stuff like that, and then I 
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take the medications for blood pressure, and I guess I could be on more medication, if I 
didn’t try to take care of myself, you know, I could be on heart medications and stuff like 
that.”   
Some participants then went on to describe the processes by which they were able 
to obtain their medicines, which frequently involved help from a community support 
worker (CSW), nurse, or pharmacist.  One participant mentioned, regarding her plan 
paperwork, “And, like if I need to go to the offices over any of that stuff, she (community 
support worker) will let me know, and if she’s available, she’ll go down there with me; if 
she ain’t, she’ll instruct me where to go and stuff like that.” 
Beneficiaries themselves did not seem to make the connection that they had few 
problems because they were receiving a great deal of help, but the help they received was 
frequently mentioned after they stated that they had few or no problems.  As one 
beneficiary commented, “So really, it’s kind of a blessing to have this, because I used to 
live on the street, and everything like that, until I got on the medicine and got involved 
with this place (community mental health agency).” 
“Having no problems” with Medicare equated with being able to get one’s 
medicines easily and at a low cost, which most beneficiaries were able to do.  An 
interviewee offered the following comment regarding Part D satisfaction:  “Well, I get 
every medication that I need, everything that I’m prescribed by my doctor, by my doctor 
here (at the mental health agency), or my doctor at my medical doctor’s office, every 
prescription they prescribe, I just take it to the same place, and they fill it.  It’s no 
problem.” 
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Several beneficiaries commented that they could not think of any way that the 
Medicare prescription drug program could be made any better.  For example, “Now, I 
don’t know, but I don’t think, like personally, they can’t do nothing to make an 
improvement to it, because my needs are being met.” 
 Affordability. 
 The phrase “I don’t have no problems” came up frequently in discussions of cost, 
as well.  Affordability of medications was the biggest factor influencing access, 
according to these beneficiaries.  If the co-payment was low, then the medication was 
accessible.  Most people did seem to think that their medications were affordable under 
Part D.  In fact, many consumers stated that they had very low co-payments, or that they 
did not pay co-payments at all at the pharmacy they used.  One consumer said, “…I don’t 
have no problem; I just call them (prescriptions) in and…go pick them up, and they’re 
ready.  I don’t have to pay for them.  Everything’s covered.”  Low cost-sharing was of 
great benefit to these participants.  As another beneficiary mentioned, “Both (mental 
health agency) and (independent pharmacy) absorb my co-pay, of three dollars or two 
dollars or whatever it is, because it’s so low, you know.” 
 All beneficiaries in the sample were dually-eligible for Medicare and Medicaid.  
However, perceptions of affordability were affected by the type of Medicaid coverage in 
which the beneficiary was enrolled.  Most beneficiaries in the sample had incomes that 
were low enough that they received full Medicaid coverage with no premium 
requirement.  A few of the beneficiaries had somewhat higher incomes and participated 
in the Missouri HealthNet (formerly Medicaid) Medically Needy program, or “Medicaid 
Spend-Down.”  Medicaid spend-down (Medically Needy) is a program under the 
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Missouri HealthNet program under which individuals whose incomes are above the 
maximum for full MO HealthNet coverage can “spend down” their income each month to 
become eligible for MO HealthNet coverage.  These beneficiaries must incur and pay for 
a certain dollar amount of medical expenses each month to activate their Medicaid 
coverage.  This dollar amount, the “spend-down,” is seen as a sort of premium for the 
Medicaid program.  Beneficiaries in this category may or may not be eligible for full 
“extra help” under Medicare Part D. 
People whose prescriptions were entirely paid for tended to be individuals with 
full Medicaid coverage—known by beneficiaries as “straight” Medicaid.  Not only did 
these individuals have the full “extra help” subsidy under Medicare Part D, but several 
local pharmacies also waived their co-payments.  For example, “Uh, I have a co-pay, like 
maybe a dollar-fifty.  Because I got a deal with Medicare Part D.  And they don’t pay all 
of it.  But (independent pharmacy), (mental health agency), absorbs my dollar-fifty.”   
Higher co-payments, or premiums for prescription drug insurance, made it harder 
to access medications.  People who were enrolled in the Missouri HealthNet Medically 
Needy program—referred to as Medicaid spend-down, whose incomes were a little bit 
higher than those of people on “straight” Medicaid, were more likely to report problems 
with co-payments or premiums, even though the Medicare program itself does not have a 
spend-down.  People in this situation frequently felt that their co-payments and premiums 
under Medicare were more than they could afford.  In addition, because their medications 
were being paid for under Medicare Part D, their expenses for prescription medicines no 
longer applied toward meeting their “spend-down,” so their eligibility for the Medically 
Needy program was sometimes affected. 
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 Problems with Medicaid coverage affected perceptions of affordability.  Problems 
with Medicaid spend-down tended to impact people’s perceptions of the entire system.  
Even though consumers with Medicaid spend-down could still get their prescription 
drugs through Medicare, the existence of the spend-down frequently confused and 
embittered consumers.  Several consumers also expressed bitterness over the lack of 
dental coverage for adults under the Missouri HealthNet (Medicaid) program.  Even 
though these issues do not directly affect Medicare coverage, they influenced consumers’ 
perceptions of health care access and affordability. 
 One issue that did affect affordability was the use of utilization management tools 
by prescription drug insurance plans.  A few beneficiaries mentioned that they were not 
able to obtain the number of pills prescribed by their doctor for a month.  One woman 
was taking Effexor twice a day, but her Part D plan would allow her to purchase only 30 
capsules a month.  She stated that she had to obtain samples or pay cash for the remaining 
capsules to get the medicine she needed.  Several other beneficiaries mentioned similar 
situations, not only with psychotropics but with blood pressure medicines and other 
medications.  They reported running out of medication in mid-month and not being able 
to obtain any more pills.  One beneficiary commented, “For your psychotropic 
medications, for certain medications, the pharmacy gives you exactly thirty days.  But 
your appointment for the doctor isn’t exactly thirty days.  So what do you do in between, 
then?”  
 Only a few beneficiaries had encountered formulary problems that affected cost 
and access.  Beneficiaries were concerned about formulary restrictiveness even if they 
had not experienced this problem personally, however. 
88 
 
 Paperwork. 
 Participants were split down the middle in terms of their opinions regarding 
information from Medicare and their Part D plans.  About half of beneficiaries reported 
that this information was helpful and that they were able to get the information they 
needed from the materials sent by their plans and by the Medicare program.  The other 
half indicated that the information they received from their Part D plans and from 
Medicare was confusing, not helpful, and much too voluminous to be useful to them.  
One typical phrase was, “It’s like a foreign language.”  Another common word that was 
used was “confusing.”  One beneficiary went so far as to say, regarding the statements he 
received from Medicare Part D, “Now me, I probably get the bill in the mail, I might 
throw it away, but really, I’m not neglecting the bill, like I’m not going to pay it…but, I 
just, you know, I can’t afford it.”  These statements were not actually bills, but the 
beneficiary did not understand their purpose and was throwing them away because he felt 
that he could not afford another medical bill. 
 Several participants who reported that the Medicare Part D information was 
helpful stated that they routinely brought their statements to their caseworkers, who 
helped them interpret the information.  Those who found Part D information to be helpful 
also seemed to appreciate the regularity with which statements and information came in 
the mail to them.  As one beneficiary said, “It’s like clockwork.” 
 Those who found Part D information not helpful also occasionally mentioned that 
they brought their statements to their caseworkers.  A couple of beneficiaries who found 
the information not helpful had negative things to say about their case workers, seeming 
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to indicate that these individuals were too busy to provide them with the information and 
guidance they were seeking. 
 Very few participants mentioned using the Medicare Web site.  A few mentioned 
calling Medicare’s help line or calling their prescription drug plan for help with 
problems.  Those who mentioned that they had used the help lines stated that they 
frequently were kept on hold for long periods of time and that they were still unable to 
get the information that they needed, although some reported satisfaction with the 
Medicare phone help line.  “I just call…Medicare…and I tell them if I’m having a 
problem what the problem is, and they tell me if it’s my problem or if it’s the doctor or 
hospital’s problem.” 
 Paperwork itself was a slightly different theme in beneficiaries’ comments.  
Beneficiaries seemed to say, “No problems, just paperwork.”  Across the three agencies, 
beneficiaries stated that there had been many forms to fill out and many letters sent from 
their Part D plans, but most beneficiaries were not bothered by the amount of paperwork.  
Again, many beneficiaries mentioned help from case workers.  For example, “I wish they 
would send me more information about my Medicare stuff, but my information comes 
from the people here, at (mental health agency).  What I would like is to get more 
information through the mail.” 
 Satisfaction with generic medicines. 
 Opinions about the use of generic medicines by Part D plans varied.  Many 
beneficiaries noted that their Part D plans preferred to pay for generic medications.  Most 
of these beneficiaries thought that generics were okay, but those who had experienced 
difficulties with generics were very vocal and concerned about this issue.  One 
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beneficiary commented,  “See, I have pins and stuff in my legs, and they have me on, 
like, this, it’s supposed to be like Vicodin, but it’s the generic, and it doesn’t work the 
same; it really doesn’t, like, I have to take more of that, and, I would just take, like one of 
the other, you know, and that’s the only problem I have with that, and see, most of my 
pain medication that they give me is a generic.  I think that’s the only problem I have, 
you know, with that.  When it comes to pain, chronic pain like that, we should be able to 
get the right thing for it, you know.” 
 Those who did not mind generics felt that the fact that they could save money by 
using generics was very important.  A common theme among those who did not mind 
generics was, “They’ve got the same potency (as the brand-name).”  Another common 
statement was, “It (the generic) works just the same.” 
Among those who objected to generics, most had had a bad experience at one 
point with taking a generic form of a medication.  Others had experienced periods of 
stability on brand-name medications and did not want to risk switching.  Several 
beneficiaries mentioned feeling somewhat threatened by their Part D plan—that they 
would be forced to accept a cheaper medication instead of the brand name that was 
working well for them.  For example, one woman had been taking a name-brand 
antipsychotic for five years and had stayed out of the hospital for that time; her Part D 
plan sent her “memos” with her monthly statement encouraging her to discuss a cheaper 
medication with her doctor.  She was reluctant to do so because the name-brand drug had 
worked so well for her, and no generic form of that particular medication was available.  
In her own words, “Like Abilify, they keep telling me I need a prescription for something 
different, because they say Abilify costs too high, in the market.  I can’t—they ain’t got 
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no generic for Abilify!  I ain’t taking a different psychotic!  Before I got started on 
Abilify, I was in the hospital like every three months.  I’m on Abilify now and I’ve gone 
for five years and I ain’t been in the hospital!” 
 Pharmacy interactions. 
 Help from pharmacists came mostly in the form of waived co-payments.  
Pharmacists also gave individualized help to beneficiaries when they ran out of medicines 
at the end of the month, perhaps lessening the effect of quantity limits.    As one 
beneficiary stated, “If I, run into a problem like I did this past weekend—I ran out of 
medications because I don’t see the doctor till today, and…the pharmacist at 
(independent pharmacy) knows me, right?  So he gave me eight days’ of medication.”   
 Interviewees also reported that the transition that had taken place between 
Medicaid drug coverage and Medicare Part D had gone smoothly from the pharmacy 
perspective.  For example, “And none of it has changed, the medicines are all the same, 
the companies may have changed, with the generics, and some of the generics look 
different.  And almost everything I get is a generic, but I don’t remember, if there was a 
change, it was a smooth transition.” 
 Participants reported high levels of satisfaction with the customer service offered 
to them at their pharmacies.  They gave examples of personalized service and effective 
communication with their pharmacists.  One beneficiary said, “I go to (independent) 
Pharmacy, and they know my medicines already, and I know the boss there; he knew me 
when I was at (assisted living facility), so I will be able to get my medicines.  Medicaid 
and Medicare, they don’t bother me.” 
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Beneficiaries were more likely to report individualized assistance from 
independent pharmacies, but those who used chain pharmacies also seemed to be 
satisfied.  In fact, one participant who used a chain pharmacy reported the following:  
“My pharmacy, dealing with them, they will help you find where you need to go.  They 
can be more compassionate, as far as providers that you come to, not only with these 
mental health consumers but with other people.  In terms of getting my medicine on time, 
the pharmacy intervention, they were right there with me.  I give them an ‘A’.”   
Another participant commented about using a chain pharmacy, “I had to go to the 
emergency room for my breathing.  And I needed a prescription filled…and the hospital 
prescription place at that time was overcrowded, and they couldn’t take me, so I had to go 
to like (chain pharmacy) or someplace like this, and since (chain pharmacy) was open 24 
hours, and it was close to where I lived, I got it taken there to get it filled, which was 
great, you know.” 
 Mental health agency interactions. 
 The phrase, “I don’t have no problems” also appeared frequently when 
beneficiaries were discussing help that they got from mental health agencies.  Most 
beneficiaries who received help from a nurse or social worker expressed confidence that 
the helper could take care of whatever difficulty they were experiencing and resolve the 
situation.  For example “You know, I called my case manager; my case manager told me 
what to do.  So I did that, sent it in, they haven’t sent me another bill.” 
However, a few (from one agency in particular) stated that although their 
community support workers tried to be helpful, they were powerless to change the 
system.  One participant commented about her community support worker’s struggles by 
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saying the following, “I have the best CSW in this place, who has advocated very 
aggressively on my behalf.  It is just that she is not able to do anything about it.  The 
problems that I’m having with my medications, and getting that straightened out, she is 
still fighting for that.” 
 Mental health agency staff played a big role in making sure people got their 
medicines.  Beneficiaries reported that agency staff assisted with co-payment costs, 
helped beneficiaries with picking up their medicines, helped to fill medicine planners, 
and communicated with physicians’ offices when formulary problems arose.  Several 
beneficiaries reported that they took the statements that they received from Medicare 
directly to their community support workers, so that they could get help in interpreting 
and understanding the content of these documents.  As one interviewee stated, “…the 
wording of the things, it’s like, we’re supposed to understand (laughs).  I don’t 
understand, so, you know, that’s why I had to have help with it, you know.  But like I 
said, I’m fine with it now, you know; as long as I get my meds, I’m good (laughs).”  
Another participant noted, “Well, I would say, my case manager said, tell me what to do, 
put those numbers in, and send it in, and I haven’t received another bill.” 
Community Support Worker Results 
 Four themes were identified throughout the community support worker coding.  
They are as follows:  Managing beneficiary problems, stress for beneficiaries, 
information and paperwork issues, and concerns about health care reform. 
 Managing beneficiary problems. 
 Managing beneficiary problems was by far the most frequently-occurring theme 
in the community support worker transcripts.  One aspect of this involved direct action or 
94 
 
advocacy that CSWs were taking on behalf of beneficiaries on Part D-related concerns.  
CSWs mentioned that they spent a considerable amount of time side-by-side on the 
phone or on the Medicare Web site, helping consumers to obtain the information that 
they needed to use and make decisions about their prescription drug benefits.  CSWs 
stated often that they felt that consumers would have had a great deal of difficulty 
managing these transactions on their own. 
 Problems also arose with physician interactions and with the process of plan 
switching.   Community support workers had to advocate on behalf of consumers with 
their physicians to obtain changes in prescriptions or to obtain necessary information to 
circumvent various utilization management issues that were standing in the way of 
consumers’ getting their medicines.  CSWs reported that dealing with physicians was 
difficult due to delays in obtaining the information that they needed.  For example, 
“…that’s been one issue, getting the physicians to fill out needed paperwork.  It’s an 
issue, unless they really are hot for the medication to get it approved, you know.”  CSWs 
also reported that physicians in general had little awareness of the details of Part D and 
were particularly lacking in knowledge regarding plan formularies:  “It’s like the doctors 
don’t know.  They don’t know what’s covered and what’s not covered.” 
 In contrast to physicians, pharmacists were universally perceived by CSWs as 
knowledgeable and helpful.  As with beneficiaries, CSWs were more likely to bring up 
specific examples of help provided by independent pharmacies, particularly the two 
independent pharmacies with which their agencies had collaborative relationships.  
However, they, too, also seemed satisfied with services provided by chain pharmacies.  
As one CSW mentioned, “I think they, they’ve been working harder with our members 
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and stuff than Medicaid or Medicare, with what was going on.”  Regarding formulary 
negotiations, another CSW stated, “They’re really good about, you know, calling and 
trying to get things covered or at least trying to get something comparable to what’s not 
covered.”  CSWs frequently collaborated with pharmacists to ensure that their clients 
were able to obtain the medicines they needed, both for physical and mental health needs.  
“I think because of our situation, because we mostly work with (independent pharmacy), 
a lot of those things were a lot smoother.” 
Plan switching also brought up problems for CSWs in helping beneficiaries.  
CSWs did not like the randomness of plan switching that occurred with the low-income 
plans each year and found themselves  having to go on line or call the various plans to 
obtain formulary and premium information for beneficiaries’ assigned plans.  The process 
of going on-line to switch plans and obtain information was not easy for many CSWs to 
negotiate, especially in the first year of the Medicare Part D program:  “…there really 
wasn’t anyone around to kind of help you navigate on the Internet and figure, and do the 
formulary and all that stuff so you can actually sign up on-line.  So that was, that was 
kind of, it was kind of aggravating, but, like I said, after a couple of times of doing it, you 
kind of figure it out.” 
 Community support workers did mention, however, that the overall 
implementation of Part D had gone more smoothly than they had expected.  They noted 
that consumers’ medication coverage had not lapsed, and that access to medicines at a 
low price was still a reality for almost all of their clients. 
 Stress for beneficiaries. 
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 Interestingly, community support workers perceived the Medicare prescription 
drug program as confusing and frightening for beneficiaries, despite the fact that the 
consumers themselves did not usually characterize the program this way.  Community 
support workers’ perception was that Part D was associated with a number of significant 
problems for beneficiaries.  Community support workers stated that the Medicare Part D 
program was a source of anxiety for many consumers and that changes in formularies, the 
large quantity of information sent by the plans, and the technical language used in plan 
communications all caused problems for consumers.  Regarding the language used by 
plans, one CSW mentioned, “It’s like that weird medicalese and legalese, and the average 
person—it’s not written for the average person to understand.” 
There was a great deal of stress and anxiety related to transition points with the 
benefit, as well; when consumers were switched from one plan to another, or when 
formularies underwent changes.  Community support workers noted that beneficiaries did 
not have a clear understanding of which health care program was paying for which health 
care benefits.  One CSW stated, “I think it’s incredibly stressful for them because they 
don’t know if the meds that they are on now are going to be covered under their plan, 
and, uh, there’s a little stress on them, if they’re going to have to start paying a monthly 
co-pay if they don’t switch plans…”  Another CSW commented on the plan switching 
process, “They say, you don’t have to do this, but they make it sound so bad, and you 
have to pay so much money if you don’t, that you’re kind of forced into whatever they 
want you to do.” 
CSWs characterized consumers as “frustrated” and “confused” regarding their 
health care benefits.  This may have been a reflection of the workers’ own feelings in 
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dealing with plan switches, formulary issues, and costs.  CSWs mentioned several points 
regarding their own confusion.  “I mean, I find it difficult to understand, and you know, 
for them, yeah, it’s like, if we’re having trouble understanding it, they’re like, it’s Greek 
to them.”  Another CSW stated, “I never understood when they first came out with the 
whole Part D thing and we all got the information, and that was so confusing,  and it was 
terrible because you had these clients asking all these questions, and you’re like, I don’t 
know, you know (laughter).  Because I don’t get it either, which is not very comforting.”   
 Information and paperwork issues. 
 Community support workers were especially concerned with the volume of 
paperwork associated with using the Medicare prescription drug benefit.  One team 
leader noted that the government “has wasted a lot of paper” on communications 
associated with the prescription drug benefit.  Community support workers did state that 
they felt that Medicare and the Part D plan sponsors had improved over the past several 
years in terms of communication and organization, but even as of 2010, some problems 
remained. 
 One issue related to information and paperwork was the observation by CSWs 
that beneficiaries frequently could not discern the difference between advertisements sent 
to them by Medicare Advantage and Medicare prescription drug plans, and consumer 
information related to their benefits.  Beneficiaries had difficulty telling the difference 
between communications from their plan to which they needed to respond and 
advertisements attempting to recruit them into a new benefit plan.  This led to some 
beneficiaries’ enrollment in Medicare Advantage plans that limited their access to needed 
medications and providers, and CSWs reported spending quite a bit of time dis-enrolling 
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consumers from Medicare Advantage plans.  One team leader noted regarding Medicare 
Advantage plan promotions, “…misrepresenting themselves, to put it mildly, to a lot of 
our members, and signing people up, and then, then they find that their doctors don’t take 
it; they can’t use it to pay doctors, and, and, in the meantime they’ve kind of run up a 
medical bill that the doctor can’t send to original Medicare.”  A CSW mentioned similar 
problems at her agency, “They (clients) get tripped up with the Advantage Care plans.  
The Medicare Advantage plans.  Because they see that and they think, well, I have to 
switch to this, not realizing that, yeah, you gain some stuff, but you lose some benefits, 
too.” 
 CSWs also observed that some beneficiaries’ distrust of “the system” and in some 
cases, symptoms of paranoia, led to problems in using the Part D benefit.  CSWs reported 
that some consumers had concerns about identity theft and destroyed needed documents 
related to their Part D plans.  Other consumers were mistrustful of switches in 
medications and coverage which led them to conclude that their medicines were being 
“tampered with.” 
 A common theme among community support workers was that they resented the 
time that they had to spend deciphering Part D paperwork and explaining consumers’ 
benefits to them.  CSWs felt that this time could be better spent on other interventions 
related to rehabilitation and community support.  For example, “We have to spend so 
much time, every year, going through this, these changes, and that’s time we could be 
spending doing other things with our clients.” 
 Concerns about health care reform. 
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 Cynicism about health care reform efforts was common among these community 
support workers.  Their perception was that the current reform efforts underway at the 
federal level were going to lead to more confusion and less access to affordable care for 
their clients.  They expressed a wish that the federal government would eliminate the 
two-year waiting period for disabled adults to receive Medicare, but doubted that this 
reform would actually take place. 
 One desire expressed by CSWs related to health care reform was the need for 
better communication regarding Medicare and the prescription drug benefit.  Several 
CSWs noted that at the state level, representatives from the Division of Medical Services 
had hosted town hall meetings and informational events to explain changes in Missouri 
HealthNet benefits.  These CSWs expressed the wish that representatives from Medicare 
or from Part D plan sponsors would host similar forums for their consumers.  CSWs felt 
that this face-to-face communication from Medicare to the beneficiaries would eliminate 
confusion and give consumers an opportunity to voice their concerns and opinions.  One 
team leader noted that a representative from a Medicare Advantage plan had hosted an 
informational event at her agency, and that this had helped consumers to understand the 
benefit better.  There was a desire on the part of CSWs to have this information separate 
from advertising or recruitment efforts related to specific plans, however. 
Plan Comparison Data:  Results 
The purpose of the quantitative analysis was to use formulary and performance 
data on the Part D program to compare plans on various attributes that contribute to 
patient-centeredness.  By evaluating the extent to which plans have attributes related to 
patient-centeredness, it is possible to determine to some degree how well plans are 
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meeting the needs of adults with mental illness.  Formulary and performance data were 
used to answer questions about respect for patients’ needs and preferences, access to care, 
information and education provided to patients, and coordination of care. 
 Part D Formularies 
   To examine the comprehensiveness of the formularies of the Part D plans, the 
www.medicare.gov Formulary Finder was used.  The following table outlines these 
findings. 
Table 4.7  Formulary Comprehensiveness 
Plan Anticonvulsants 
Covered 
Antidepressants 
Covered 
Antipsychotics 
Covered 
Aetna Medicare Rx 
Essentials 
100% 100% 100% 
Community CCRx 
Basic 
80% 47% 82% 
First Health Part D- 
Premier 
80% 47% 82% 
Health Spring 
Prescription Drug 
Plan-Reg 18 
87% 47% 91% 
Medco Medicare 
Prescription Plan-
Value 
67% 47% 82% 
 
   The Medicare Rx Rewards Standard Plan is not included in this table because 
formulary data for this plan were not available at the time that the data were being 
collected.  Coverage for anticonvulsants is quite comprehensive with the first four plans 
examined, although Medco Medicare Prescription Plan-Value covers only 2/3 of the 
anticonvulsants in Huskamp et al.’s list.  Coverage for antidepressants does not appear to 
be as good, with four of the five plans covering less than half of antidepressants on the 
list.  However, many of the antidepressants that are not covered are those brand-name 
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drugs that have generic equivalents at this time, such as Celexa, Prozac, and Paxil.  
Coverage for antipsychotics is fairly good, with the lowest percentage of antipsychotics 
covered at 82% for three of the five plans.  Coverage for anticonvulsants and atypical 
antipsychotics may be better than coverage for antidepressants because there are fewer 
generic alternatives for many of the anticonvulsants and antipsychotics than there are for 
the antidepressants.  This is consistent with the Centers for Medicare and Medicaid 
Services regulation stating that “all or substantially all” drugs in these classes must be 
covered by all Part D plans (Huskamp, 2007). 
   Aetna Medicare Rx Essentials covers all of the three classes of drugs listed, but this 
plan also uses quantity limits for almost all antidepressants and antipsychotics on the list. 
Part D Utilization Management Strategies 
   The www.medicare.gov Formulary Finder was also used to identify which 
utilization management strategies are being used by each Part D plan.  Utilization 
management strategies are processes used by prescription drug insurance plans to limit 
coverage of expensive medications.  The three primary utilization management strategies 
used by Part D plans are prior authorization, quantity limits, and step therapy.  Prior 
authorization is used when a Part D plan requires written permission from a beneficiary’s 
prescribing health care provider before a particular drug will be prescribed.  Quantity 
limits are enforced when a beneficiary can only receive a certain quantity of medication 
during a specified time period.  For example, a beneficiary may be limited to obtaining 
thirty tablets of a medication during a 30-day period.  Step therapy, also known as “fail-
first,” occurs when a beneficiary must provide evidence to his/her prescription drug plan 
that a less expensive medication is ineffective for him/her before a more expensive 
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(usually brand-name) medication will be covered.  The following table outlines the 
percentage of each class of medications that is subject to each form of utilization 
management. 
Table 4.8  Utilization Management Strategies 
Plan Prior 
Authorization 
Quantity Limits Step  Therapy 
Aetna Medicare Rx 
Essentials 
 
 
Anticonvulsants 
Antidepressants 
Antipsychotics 
 
 
0% 
0% 
0% 
 
 
13% 
100% 
81% 
 
 
7% 
68% 
27% 
Community CCRx 
Basic 
 
 
Anticonvulsants 
Antidepressants 
Antipsychotics 
 
 
8% 
0% 
11% 
 
 
17% 
56% 
100% 
 
 
0% 
22% 
0% 
First Health Part 
D-Premier 
 
Anticonvulsants 
Antidepressants 
Antipsychotics 
 
 
8% 
0% 
56% 
 
 
17% 
33% 
89% 
 
 
0% 
11% 
0% 
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HealthSpring 
Prescription Drug 
Plan –Reg 18 
 
 
 
Anticonvulsants 
Antidepressants 
Antipsychotics 
 
 
 
0% 
0% 
0% 
 
 
 
0% 
78% 
80% 
 
 
 
0% 
0% 
0% 
Medco Medicare 
Prescription Plan-
Value 
 
 
Anticonvulsants 
Antidepressants 
Antipsychotics 
 
 
 
0% 
0% 
0% 
 
 
 
0% 
100% 
78% 
 
 
 
0% 
0% 
0% 
 
Prior authorization was used relatively infrequently by all five plans  The highest 
use of prior authorization can be seen with First Health Part D-Premier, in its coverage of 
antipsychotics, in which 56% of atypical antipsychotics covered by the plan require prior 
authorization from a health care provider before the plan will pay for them.  When prior 
authorization is used, it is often used with brand-name drugs that are quite expensive and 
that have no generic alternative.   
Quantity limits were the most commonly-used utilization management strategy, 
employed by all five of the plans.  Quantity limits were especially common in coverage 
of antidepressant medications; two of the five plans required quantity limits for all 
antidepressant prescriptions, and two additional plans required quantity limits for more 
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than half of antidepressant prescriptions.  Quantity limits were also frequently employed 
with atypical antipsychotic medications, with all five plans using quantity limits for over 
three-quarters of atypical antipsychotic prescriptions.  For most patients, the use of 
quantity limits does not affect access to the medicines they need, but for patients who 
require more than one daily dose of a particular medicine, quantity limits can create a 
problem. 
Step therapy was not used at all by two of the five plans.  Aetna Medicare Rx 
Essentials required step therapy for about two-thirds of antidepressants.  Community 
CCRx and First Health Part D-Premier used step therapy for a small number of 
medications.  Plans may use step therapy because they want patients to try cheaper 
medications first before switching to expensive brand-name drugs.  Both prior 
authorization and step therapy require considerable documentation and paperwork on the 
part of patients’ physicians. 
 There is a certain amount of interplay between formulary coverage and use of 
utilization management tools.  Some plans take the approach that they will have all drugs 
on formulary, but will restrict their use through quantity limits or step therapy (for 
example, Aetna Medicare Rx Essentials).  Other plans have more limited formularies, but 
they do not use utilization management tools as extensively (for example, Medco 
Medicare Prescription Plan). 
Medicare Part D Performance Data 
 The Medicare Part D performance data were used to answer three questions 
related to the patient-centeredness of the benchmark plans.  The first question was:  What 
percentage of plan members feel that the drug plan provides information or help when 
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members need it?  Adequate information and education about health care has been 
identified as a key aspect of patient-centered care.  The following table summarizes the 
percentage of members in each plan who expressed satisfaction with the information and 
education provided by their plan. 
Table 4.9  Provision of Information and Help When Members Need It 
Plan Percentage of plan members who feel that the plan 
provides information or help when members need it. 
Aetna Medicare Rx Essentials 77.7% 
 
Community  CCRx Basic 76.8% 
 
First Health Part D-Premier 79.1% 
 
Health Spring Prescription 
Drug Plan-Reg 18 
79.0% 
 
 
Medco Medicare Prescription 
Plan-Value 
80.4% 
 
 
Medicare Rx Rewards 
Standard 
75.4% 
 
 
 
Over three-quarters of members in every benchmark plan felt that information and help 
was provided by the plan when they needed it.  The lowest percentage was Medicare Rx 
Rewards Standard, for which 75.4% of members expressed satisfaction with information 
and help provided by the plan.  The highest percentage was Medco Medicare Prescription 
Plan-Value, for which 80.4% of members expressed satisfaction with information and 
help provided by the plan.  There is so little variation that the question of patients’ 
diligence in reporting problems and satisfaction is raised. 
A second question that was asked using the Medicare Part D performance data 
was:  What is the rate of complaints about drug plan benefits and access to prescription 
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drugs?  This is an important question because it touches on levels of satisfaction 
regarding beneficiaries’ ability to obtain certain medications and to use their benefits to 
get what they need.  The rate of complaints in this area was extremely low across all of 
the plans studied.  This may be because patients do not complain to the Centers for 
Medicare and Medicaid Services when they have problems with their plans.  Patients may 
not even realize that they have the right to register a complaint.  Alternatively, it may also 
be because most people are getting what they need from Part D. 
Table 4.10  Rate of Complaints About Drug Plan Benefits and Access to Prescription 
Drugs 
Plan Rate of complaints (per 1000 members) 
Aetna Medicare Rx Essentials 0.07 
Community CCRx Basic 0.04 
First Health Part D-Premier 0.07 
HealthSpring Prescription Drug Plan-Reg 
18 
0.05 
Medco Medicare Prescription Plan-Value 0.04 
Medicare Rx Rewards Standard 0.05 
 
The third question examined using Part D performance data was as follows:  
What is the rate of complaints about joining or leaving specific prescription drug plans?  
This is a particular issue for dually-eligible beneficiaries because they may be randomly 
assigned to plans that are not the best “fit” for their needs and may need help switching to 
a plan that has a more appropriate formulary or pharmacy network. 
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Table 4.11  Rate of Complaints about Joining or Leaving Specific Prescription Drug 
Plans 
Plan Rate of complaints (per 1000  members) 
Aetna Medicare Rx Essentials 0.61 
Community CCRx Basic 0.39 
First Health Part D-Premier 0.87 
Health Spring Prescription Drug Plan-Reg 
18 
0.31 
Medco Medicare Prescription Plan-Value 0.61 
Medicare Rx  Rewards Standard 0.37 
 
 Rates of complaints about this aspect of the prescription drug plans appeared very 
low, as well, although they are higher than rates of complaints about benefits and access.  
As with complaints about access and benefits, patients may not be aware of the 
mechanisms for registering complaints with CMS.  In addition, there may be few 
complaints because patients do not switch plans very often (Dulio, Perry, & Cubanski, 
2007). 
Conclusion 
The qualitative and plan comparison data examined here offer a look inside the 
world of the Part D benefit.  That world is characterized by satisfaction on the part of 
beneficiaries, and cynicism on the part of community support workers.  The plan 
comparison data reinforce the high levels of beneficiary satisfaction. 
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The overwhelming perspective of beneficiaries seems to be that Medicare Part D 
works well in providing low-cost, accessible prescription medications.  Though 
satisfaction is high and complaints are low, there are still a few access issues, as well as 
problems with information and education about plans.  However, the impact of existing 
problems with Medicare Part D appeared to be moderated by the assistance provided by 
community support workers and pharmacists.  Interviewees frequently mentioned the 
importance of the help they received in being able to use their prescription drug benefits.  
Beneficiaries acknowledged the extensive assistance they received both from mental 
health agencies and from pharmacies in using their Part D benefits and accessing their 
medications.  The consistent mention of the critical role of this help came as a surprise. 
Community support workers were much more likely than beneficiaries 
themselves to mention problems with access and plan information.  Many community 
support workers had experienced problems with plan switching and with confusing 
information provided by plans.  Community support workers reported spending 
considerable amounts of time deciphering plan information and negotiating the Medicare 
Web site with their clients.  An attitude of cynicism and frustration permeated CSWs’ 
discussion not only of the Part D program, but of national health reform efforts, as well.   
Plan comparison information revealed only a few complaints about the Part D 
program.  In some respects, the plan comparison data painted an even more positive 
picture of the patient-centeredness of the Part D program than even the qualitative 
findings from beneficiaries.  The low incidence of complaints about Part D plans was 
somewhat surprising.  Formularies appeared to cover the majority of psychotropic 
medications, but there were some access issues concerning brand-name drugs that 
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affected a few beneficiaries.  Utilization management tools, especially quantity limits, 
were a common cost-containment strategy for Part D plans.  Satisfaction with 
information provided appeared high overall, and rates of complaints about benefit plans 
and plan switching were extremely low.  Examination of the plan comparison data in 
light of the qualitative findings will reveal further insights into the patient-centeredness of 
the Medicare Part D program. 
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CHAPTER V:  DISCUSSION AND CONCLUSIONS 
Introduction 
 This chapter discusses the qualitative and plan comparison findings and their 
relationship to patient-centered care.  Principles of patient-centered care are compared 
with codes discerned in the qualitative data, as well as with findings related to the plan 
comparison data.  Focus group and interview data are triangulated with plan comparison 
data to determine whether “benchmark” plans are adhering to important principles of 
patient-centered care.  Following this discussion, the findings are summarized, and 
implications for social work research, policy and practice, and education are outlined. 
Qualitative Data Analysis:  Consumer Codes and Patient-Centeredness 
 After stakeholders’ experiences with the Medicare program were coded and 
sorted, data were examined to discover relationships between experiences with Medicare 
Part D and principles of patient-centered care.  A deductive approach was used; concepts 
related to patient-centered care were used to organize and understand the data codes 
(Morse & Field, 1995).  With the consumer data, each code was found to relate to at least 
one patient-centered care characteristic, as seen in the following table. 
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Table 5.1.  Consumer Data Codes and Patient-Centered Care Principles 
 
Data Code Patient-Centered Care Principle(s) 
Concerns about health care reform Information and education 
Co-payments okay Access to care (there is not a patient-centered 
care principle directly related to cost) 
Co-payments not okay Access to care 
Costs okay Access to care 
Costs not okay Access to care 
Dental insurance problems Respect for the patient’s values, preferences 
and expressed needs; access to care 
Formulary problems Respect for the patient’s values, preferences 
and expressed needs; access to care 
Generic drugs okay Respect for the patient’s values, preferences, 
and expressed needs; access to care 
Generic drugs not okay Respect for the patient’s values, preferences, 
and expressed needs; access to care 
Help from mental health agencies Information and education; emotional support 
to relieve fear and anxiety; continuity and 
secure transitions between health care settings; 
coordination of care 
Help from pharmacists Information and education; continuity and 
secure transitions between health care settings; 
coordination of care 
Information from Medicare helpful Information and education; coordination of 
care 
Information from Medicare not helpful Information and education; coordination of 
care 
Medicaid spend-down Access to care; continuity and secure 
transitions between health care settings; 
coordination of care 
Not satisfied with Part D Respect for the patient’s values, preferences, 
and expressed needs 
Satisfied with Part D Respect for the patient’s values, preferences, 
and expressed needs 
Paperwork Information and education; coordination of 
care 
Problems with Medicare Advantage Access to care; coordination of care 
Problems with utilization management (in Part 
D plans) 
Respect for the patient’s values, preferences, 
and expressed needs; access to care 
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 Patient-centered care principles are relevant to the concerns of individuals with 
serious mental illness because there are so many similarities between the concept of 
patient-centered care and principles of quality mental health care (Mechanic, 2007; 
Pincus et al., 2007).  The most critical principles of patient-centered care for adults with 
serious mental illness, according to this analysis, appear to be access to care (which 
includes affordability); respect for the patient’s values, preferences, and expressed needs; 
and information and education.   
Another reason that patient-centered care principles are important to adults with 
serious mental illness has to do with the impact of mental illness stigma.  The stigma of 
mental illness has left many adults with mental illness disempowered and disenfranchised 
(Corrigan, Watson, Byrne, & Davis, 2005).  When health care programs enact principles 
of patient-centered care, they can accomplish much to undo the harmful effects of stigma.  
Respect for patients’ values, as well as information and education, are particularly 
important in this regard. 
Consumers’ Assessment of Patient-Centeredness of Medicare Part D 
 In terms of access and attention to individual patients’ needs, beneficiaries gave 
the Part D program high marks.  With a few exceptions, most beneficiaries felt they were 
able to obtain their medicines through Part D inexpensively and without much hassle:  “I 
don’t have a problem getting my medicine” and “Part D is working for me.”  This is 
congruent with the observations of Neuman and Cubanski (2009) regarding low-income 
subsidy-eligible beneficiaries, who had lower out-of-pocket costs than they had had under 
Medicaid.  Duggan et al. (2008) also note that overall, Medicare Part D has increased 
access to prescription medicines for beneficiaries.  Qualitative observations from the 
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“Voices of Beneficiaries” project also note high overall satisfaction with Part D access 
and cost (Kaiser Family Foundation, 2006; Perry et al., 2006).  Though there were a few 
complaints about access to brand-name medications, for most beneficiaries this was not a 
problem.   
In terms of information and education related to Part D plans, beneficiaries were 
not as satisfied.  Though some consumers appreciated the information provided by Part D 
plans, others found the amount of paperwork confusing.  Some beneficiaries found plan 
communications to be helpful in deciphering their benefits, but others felt that the 
language used in statements sent by plans was not easily understood.  As one interviewee 
noted, “It was hard for me to understand the way that some of that, the way they word it, 
you know, it’s really difficult.”  Dulio, Perry & Cubanski (2007), in their interviews of 
Part D beneficiaries, found similar results—that beneficiaries had difficulty 
understanding paperwork associated with the benefit.   
The “piece of the puzzle” that seemed to make the prescription drug benefit 
manageable for these beneficiaries was the extensive help they got from pharmacists and 
workers at community-based mental health agencies.  This help from pharmacies and 
mental health agencies was directly associated with the patient-centered care attribute of 
continuity and secure transition between health care settings.  This assistance made the 
program more patient-centered for participants, enhancing perceptions of respect for 
patients’ values and needs, as well as access to care.  As one beneficiary mentioned about 
his pharmacy, “I guess I don’t have a problem.  They (the pharmacists) know who I am 
when I call.”  The Part D benefit itself did not adhere so well to expectations of patient-
centeredness, but the assistance provided by community helpers definitely seemed 
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focused on the well-being of the consumers.  Perry, Dulio and Cubanski (2006) also 
mention the role of pharmacists as advocates for Part D beneficiaries, and an earlier 
Kaiser Family Foundation report (2006) discusses the role of community-based case 
managers in assisting with plan selection.  Shrank et al. (2006) mention the assumption of 
many physicians that it is the role of pharmacists to assist patients in managing costs.  In 
terms of managing the stress and anxiety associated with Part D, as Zagar states, “The 
technical components of Medicare Part D can be ‘learned,’ but the emotional aspects 
associated with this program can only be ‘experienced.’” (2007, page 5).  Community 
support workers and pharmacists not only provided the technical help with interpreting 
benefits and obtaining medications; they also supported beneficiaries and lessened 
anxiety and confusion about use of the program. 
Qualitative Data Analysis:  CSW Codes and Patient-Centeredness 
 CSW codes were also mapped onto patient-centered care characteristics using a 
deductive theory approach. 
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Table 5.2  Community Support Worker Data Codes and Patient-Centered Care Principles 
 
Data Code Patient-Centered Care Principle(s) 
Action on behalf of consumer Information and education; emotional support to 
relieve fear and anxiety; continuity and secure 
transitions between health care settings; 
coordination of care 
Communication with members Information and education; coordination of care 
Costs Not Okay Access to care 
Costs Okay Access to care 
Dealing with Bureaucracies Information and education; coordination of care 
Health Care Reform Information and education 
Part D Okay Respect for the patient’s values, preferences, and 
expressed needs 
Pharmacies helpful Information and education; continuity and secure 
transitions between health care settings; 
coordination of care 
Prescription Issues Respect for the patient’s values, preferences, and 
expressed needs; access to care 
Problems with Medicare 
Advantage 
Access to care; coordination of care 
Problems with physicians Coordination of care; continuity and secure 
transitions between health care settings 
Problems with Switching Plans Coordination of care; access to care 
Stress for consumers Information and education; access to care; 
emotional support to relieve fear and anxiety 
Utilization Management Respect for the patient’s values, preferences, and 
expressed needs; access to care 
 
 Community support worker codes were mapped onto patient-centered care 
principles because CSWs play a critical role in ensuring that beneficiaries experience 
health care in a patient-centered way.  The concept of client-centeredness has been used 
to assess the quality of public social services, and is considered important in 
understanding reasons for clients’ satisfaction with such programs (Jindani & Murdock, 
2009).  The most important principles of patient-centered care for the community support 
workers interviewed for this study appear to be access to care, coordination of care, and 
information and education.  Coordination of care appears as a prominent principle of 
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patient-centered care for these CSWs, most likely because they play such an important 
part in coordinating programs for the beneficiaries they serve. 
CSWs’ Assessment of Patient-Centeredness of Medicare Part D 
 Community support workers were not as positive as beneficiaries in their 
evaluation of the Medicare prescription drug benefit.  CSWs felt that continuity and 
secure transition between plans and between formularies was lacking, and that they were 
frequently called upon to make these transitions happen.   Community support workers 
were almost entirely negative about the information and education provided by Part D 
plans, feeling that there was too much of the wrong kinds of information.  CSWs noted 
repeatedly that they themselves had difficulty understanding communications from Part 
D plans, and they observed that individuals with less education or lower literacy would 
have an even harder time deciphering plan information.  As one CSW stated, “For me, I 
know it was confusing for a lot of people.”  Another CSW recommended, “Give 
members greater understanding.  Members want more information.” 
Community support workers expressed cynicism and frustration with the 
operation of Part D plans, and even though CSWs noted that the implementation of Part 
D had not been quite as chaotic as they had expected, there were still substantial 
problems with plan communications.  Nonetheless, in terms of access to care, community 
support workers did note that beneficiaries were able to obtain their medicines cheaply 
and that few lapses in coverage had actually taken place.  One community support worker 
noted, “But as far as their psych meds, everything’s pretty much covered; um, their 
regular medical meds are pretty much covered.  We haven’t had too many issues.”  The 
resounding theme of CSWs’ comments, however, was that consumers would not be able 
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to manage this benefit on their own.  Not only instrumental help, but the emotional 
support to relieve consumers’ fear and anxiety, were viewed as essential to assisting 
consumers to manage the Part D program.  A CSW mentioned, “It’s scary for someone 
who’s paranoid already.” 
Community support workers put a great deal of effort into making the Part D 
benefit plan work well for their clients, but they rated the Part D plan quite poorly in 
terms of continuity of care and access to care.  These findings are similar to the 
observations of Buchsbaum et al. (2007), who found in their key informant interviews 
that health care and social service professionals had to provide much assistance to dually-
eligible beneficiaries related to Medicare Part D.  From case managers’ perspectives, 
beneficiaries experienced satisfactory access and continuity/secure transitions because of 
the assistance they received; for example, “It took hours and hours to, on the computer, 
with the member sitting next to me, to plow through the system and try to get some 
information.” 
Plan Comparison Data:   Discussion 
Plan comparison data were used to assess five different patient-centered care 
characteristics.  These were as follows:  Respect for the patient’s values, preferences, and 
expressed needs (formulary coverage); access to care (use of utilization management 
tools); coordination and integration of care (complaints regarding plan benefits); 
information, communication, and education (satisfaction with plan information); and 
transition and continuity (complaints regarding plan switching).   
Formulary coverage is a key dimension of respect for patients’ needs.  Formulary 
restrictions are commonly used by both commercial and publicly-funded prescription 
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drug plans to control costs, and some research shows that the cost-containment function 
of formulary restrictions is fairly effective (Maio, Pizzi, Roumm, Clarke, et al., 2005).  In 
terms of formulary coverage of psychotropic medications in the six benchmark plans 
studied, most plans appeared to have fairly comprehensive coverage.  The only exception 
to this was that certain brand-name antidepressants which have generic equivalents were 
not covered.  This creates a problem for beneficiaries who cannot tolerate generic 
preparations, but for most patients this is not an issue.  In the qualitative data collected 
regarding use of generic medicines, most beneficiaries appeared satisfied with generic 
preparations.  One beneficiary did state that generic medicines were not effective for her, 
and that her physician had specified that she should take a brand-name drug.  Duggan et 
al. (2008) mention that Part D plans frequently put in place strong incentives for 
beneficiaries to used generic medicines; for most beneficiaries, this is not viewed as a 
problem.  Huskamp (2003) has noted that therapeutic substitution of one mental health 
drug for another is less easily done than with drugs for other medical conditions, but for 
most of the beneficiaries in the qualitative sample, this was not an issue. 
Focus group participants—both beneficiaries and community support workers—
agreed that plan formularies rarely caused a problem for them, as the medicines 
beneficiaries needed were almost always covered.  Plans did reasonably well in 
respecting the patient’s values, preferences, and expressed needs.  The “incented 
formulary” (Maio et al., p. 121) structure of these plans—placing generic and brand-
name drugs on different tiers of coverage—did not bother most beneficiaries and seemed 
to serve their needs reasonably well, as even co-payments for brand-name preparations 
were fairly low and often waived by pharmacies. 
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Use of utilization management tools varied among the plans.  The only utilization 
management tool mentioned often by beneficiaries was quantity limits.  According to 
Olson (2003), quantity limits are frequently used by commercial pharmacy benefit plans 
as a way to contain costs.  Though they are somewhat effective at managing prescription 
drug spending, quantity limits can create problems.  For example, one study found an 
association between plans’ use of quantity limits and transfers of beneficiaries to higher 
levels of care (Olson, 2003). 
In the focus group data collected, one beneficiary in particular had experienced 
difficulty obtaining adequate amounts of an antidepressant she needed.  She reported that 
this had resulted in an unwanted hospitalization.  Several other participants reported 
encountering quantity limits in prescriptions for medical conditions, such as 
hypertension.  Beneficiaries saw quantity limits as unfair, feeling that the insurance 
company should not have the right to specify how much medicine their doctors could 
prescribe for them.  Community support workers also reported problems with quantity 
limits, stating that when their clients dropped or lost medicine, or were “overcompliant,” 
they could run out of medicine and not be able to obtain more when they needed it. 
The literature on utilization management tools in pharmacy benefit plans makes 
frequent mention of prior authorization as a cost-control strategy (Olson, 2003; Maio et 
al., 2005).  Prior authorization is seen as effective at reducing utilization of new and 
expensive medications, but it involves a considerable administrative burden that can 
actually increase costs to prescription drug plans (Olson, 2003).  This additional 
administrative cost is one likely explanation for the infrequent use of prior authorization 
among the Part D benchmark plans studied.   
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In terms of access to care, plans frequently used utilization management, 
especially quantity limits, to control costs.  Some beneficiaries were upset by this, but 
overall, utilization management was not a common barrier to obtaining the medicines that 
beneficiaries needed or preferred.  This is in contrast to the observations of Donohue et 
al. (2009) who stated that implementation of utilization management tools for 
psychotropic medications was likely to increase.   
Medicare Part D performance data revealed some interesting information about 
consumer satisfaction with several aspects of their prescription drug benefits.  One of the 
most fascinating aspects of these data is the overwhelmingly high levels of satisfaction 
with Part D plans expressed by beneficiaries.  This is in contrast to much of the literature 
on satisfaction with managed care plans, which indicates that benefit plans that highly 
“manage” (Landon, Rosenthal, Normand, Frank, et al., 2008) provision of services to 
beneficiaries tend to have lower satisfaction ratings (Schur, Berk, & Yegian, 2004; 
Landon et al., 2008).  Gillies, Chenok, Shortell, Pawlson, & Wimbush (2006) also found 
that affiliation with a national managed care organization (a frequent feature of Part D 
plans) was correlated with lower patient satisfaction ratings.  One interesting assessment 
of consumer satisfaction with managed care, however, found that the level of care 
management in benefit plans did not affect the satisfaction ratings of patients with 
depression (Grembowski, Paschane, Diehr, Katon, et al., 2007). 
In terms of satisfaction with information and help provided by plans, over three-
quarters of plan respondents stated that they were satisfied with these aspects of their Part 
D plans.  These results correspond well with the qualitative data on overall levels of 
satisfaction that were collected, in which very few beneficiaries expressed dissatisfaction 
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with their Part D plans.  The rate of satisfaction with plan information and help seems 
somewhat high compared to the qualitative question of plan information, in which about 
half of beneficiaries reported having some problem understanding or interpreting 
information they received from their plans.  However, the qualitative data come from a 
small and non-representative sample, so a discrepancy between the qualitative data and 
the Part D performance data is not unexpected.  Beneficiaries polled by the Centers for 
Medicare and Medicaid Services expressed high levels of satisfaction with plan 
information, and there was little variation among the plans.  Beneficiaries surveyed were 
mostly happy with the information provided by their plans.  An interesting discovery 
about communication is that a higher percentage of people are satisfied with their drug 
plan’s communication with them than are satisfied with their physician’s communication 
with them (CMS, 2009, AHRQ, 2008).  The qualitative results are definitely more mixed, 
it may be that the Part D program appears to be doing well on information, 
communication, and education for beneficiaries largely because of the help that 
beneficiaries receive from pharmacists, nurses, and community support workers. 
Another question asked of the plan comparison data concerned the rate of 
complaints among plans regarding plan benefits and coverage.  Complaints about plan 
benefits appear to be very infrequent in all plans.  There is very little variation among 
plans with this question.  In the qualitative findings explored in this study, it did appear 
that most beneficiaries questioned about formulary and access issues appeared highly 
satisfied about this aspect of their prescription drug plans.  Beneficiaries reported being 
able to obtain the medicines they needed from their chosen pharmacies.  Some 
coordination and integration issues arose with plans during the switch in 2006 from 
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Medicaid to Medicare for dually-eligible beneficiaries.  Coordination and integration of 
care, though noted in the qualitative findings as a source of some initial problems for 
beneficiaries and case managers, did not appear as an area of difficulty in the plan 
comparison data.  The rates of complaints regarding plan benefits and ability to obtain 
prescription medications were very low.  This is a positive finding for beneficiaries with 
mental illness, as Simoni-Wastila et al. (2008) found that Medicare beneficiaries with 
severe mental illness were less likely to obtain prescription drugs for their mental health 
conditions if they had discontinuities in their drug coverage.  A finding of adequate 
coverage and benefits for Medicare beneficiaries is also positive because limits on 
prescription drug coverage can be associated with non-adherence and later health 
problems (Hsu et al., 2006). 
The final question that was asked of Part D performance data concerned the rate 
of complaints about plan switching.  There is more variability among plans on this 
question, but rates of complaints are still very low.  Although beneficiaries did not 
frequently mention problems with plan switching during the qualitative data collection 
for this study, community support workers did mention plan switching as a source of 
stress both for themselves and for the beneficiaries they were working with.  Community 
support workers noted that using the Internet to switch a beneficiary’s plan could be a 
confusing process for the client.  It may be, however, that beneficiaries and their helpers 
are not using formal avenues for filing complaints to register the problems they are 
having with the plan switching process.  Transition and continuity were sources of some 
complaints on the part of beneficiaries, as they noted some problems with the plan 
switching process.  This appeared as a bit of a flashpoint in the qualitative data for CSWs, 
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as well, as they mentioned frequently problems with plan switching among their clients.  
Neuman and Cubanski (2009) have noted that the random assignment of dually-eligible 
beneficiaries to benchmark plans can be a source of trouble and confusion. 
Summary of Findings 
The goal of this study was to use the framework of patient-centered care to gain a 
better understanding of how well Medicare prescription drug policy meets the needs of 
beneficiaries with severe and persistent mental illness.  Eliciting the perspectives, 
experiences, and opinions of Medicare Part D stakeholders has illuminated the various 
policy dimensions that are considered the most important in prescription drug benefit 
plans.  A look at data comparing “benchmark” plans confirmed the opinions and 
experiences of beneficiaries and their helpers. 
Several conclusions can be drawn from the findings of this study.  One important 
observation is that low-income beneficiaries with mental illness express high levels of 
satisfaction with the Medicare Part D program.  Beneficiaries report few problems with 
the benefit and seem, for the most part, to accept the costs and paperwork associated with 
the Part D benefit. 
For dually-eligible beneficiaries, the switch to the Medicare prescription drug 
program from Medicaid has not meant big problems, but it has not improved access or 
affordability (Donohue & Frank, 2007).  Beneficiaries report high levels of satisfaction 
with their prescription drug benefits, and they do not report many problems with 
obtaining medications as a result of switching from Medicaid to Medicare.  Costs seem 
about the same.  In addition, there is much more paperwork and bureaucracy to deal with 
than there was under a single state-administered program (Hall, Kurth, & Moore, 2007).  
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Beneficiaries report receiving monthly statements from their prescription drug plans, 
enabling them to track more closely their prescription drug expenses but also giving them 
one more piece of paper to read each month.  Communications from Medicare and Part D 
plans are appreciated, but not always experienced as readable or ultimately very helpful. 
It is important to note, too, that for low-income people using Medicare Part D, 
access often equals affordability.  Comments about how much things cost were much 
more prominent than other access-related concerns such as pharmacy networks.  This 
may have been because their pharmacies accepted their plans, or because under current 
Part D regulations “all or substantially all” of mental health drugs must be covered by 
plan formularies (Huskamp et al., 2007).  Major patient-centered care themes for 
beneficiaries were access to care; information, communication, and education; and 
continuity and secure transitions. 
Beneficiaries with mental illness used the services of their community support 
workers extensively.  Case workers are spending a great deal of time and energy on the 
paperwork associated with this benefit program.  This is a source of frustration for 
community support workers, who would like to spend their efforts on more fruitful 
rehabilitative services. 
Community support workers’ perspective on this benefits program is quite 
different from that of beneficiaries.  Though Medicare beneficiaries did not mention 
stress associate with using their prescription drug plan, community support workers 
perceived Part D as a source of stress for their clients.  Also, a frequent theme in CSWs’ 
comments about this program was dealing with problems associated with the benefit.  
Problems included issues with paperwork and bureaucracy, communication with other 
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professionals, and plan switching.  Community support workers noted frequently the 
importance of emotional support to relieve fear and anxiety, as well as adequate plan 
information and communication, to effective use of the Part D program. 
When examining plan comparison data, it appears that formulary coverage for 
most psychotropic medications is quite good.  Plans do use some utilization management 
tools to control costs.  Data on plan complaints and plan satisfaction seem to confirm 
what consumers have to say about Part D; that is, that most beneficiaries are satisfied 
with most aspects of their benefit plans.  It is difficult to say whether these high levels of 
satisfaction truly reflect beneficiaries’ experiences with Part D, or whether beneficiaries 
are not empowered enough to register their complaints.  Participants in the qualitative 
focus groups and interviews, however, seemed reasonably empowered to express their 
opinions, and they did report overall satisfaction with the Part D program.  Plan 
comparison information does seem to capture the most relevant aspects of patient-
centered care for beneficiaries and their helpers, with the exception of emotional support, 
which neither Medicare Web site nor Part D performance data are able to describe 
adequately. 
Conclusions:  Is Medicare Part D A Patient-Centered Program? 
 To assess the patient-centeredness of the Medicare Part D program, it is beneficial 
to re-visit the five attributes of patient-centered care identified by the investigator as 
applying to patient-centered programs (see pp.46-47) .  These are accessibility, care 
coordination, involvement of the patient, information and education, and secure 
transitions.  These will be considered one at a time to determine how they apply to 
Medicare Part D. 
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Accessibility 
 Access comprises several different ideas, including affordability as well as ability 
to obtain needed medications.  In terms of affordability of care, Part D seems to meet this 
criterion of patient-centeredness.  Neither beneficiaries nor community support workers 
reported major issues with co-payments or other issues related to affordability.  In 
addition, access to needed medications was generally perceived as acceptable.  Only a 
few beneficiaries reported problems with generic medications or formularies.  
Beneficiaries who were participating in the Medically Needy (“spend-down”) program or 
who had mistakenly enrolled in Medicare Advantage plans reported some access 
problems, but these were not frequent complaints. 
Care Coordination 
 Beneficiaries experienced coordination of care, but it was not due to any effort by 
Medicare Part D plans or the Medicare program itself.  Care coordination was a function 
of the persistent advocacy of community support workers and other helpers on behalf of 
their clients.  Community support workers in particular noted that coordination between 
Medicare and Medicaid programs was lacking, and beneficiaries often had little 
awareness of which program was paying for what health care service.  Medicare Part D 
does not offer much coordination of care to beneficiaries. 
Involvement of the Patient 
 Through Web-based tools such as the formulary finder and on-line plan 
enrollment, Part D attempts to involve patients in choices about their own care.  The Part 
D program has made an effort to empower patients to make plan decisions.  
Unfortunately, these Web-based sources of choice and information are often not 
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accessible to the most economically vulnerable Medicare beneficiaries.  Low-income 
Medicare beneficiaries with mental illness reported that they rarely used the Internet to 
make plan comparisons or enroll in Part D plans.  Community support workers had 
become adept at using the www.medicare.gov Web site out of necessity, but involvement 
of CSWs does not equate with involvement of beneficiaries.  Beneficiaries were auto-
enrolled into Part D plans in 2006 and again as the “benchmark” status of their plans 
changed, and they rarely challenged or changed these enrollments unless urged to do so 
by a community support worker. 
Information and Education 
 Again, through Web-based resources, the Medicare program is attempting to 
provide information and education to Medicare beneficiaries.  Monthly statements also 
provide communication from Part D plans to their enrollees.  Information from plans and 
from Medicare remains confusing, however, and in the case of Web-based information, 
largely inaccessible to those who need it most.  The Medicare Part D program needs 
much improvement in the area of keeping beneficiaries informed and educated. 
Secure Transitions 
 By auto-enrolling dually-eligible beneficiaries into “benchmark” Part D plans, the 
Medicare program did ensure continuity of care for these individuals as they transitioned 
from Medicaid to Medicare.  Auto-enrollment each year as benchmark plans change also 
ensures secure transitions.  However, random plan assignment does not always ensure 
that beneficiaries are enrolled in the plan that best suits their needs.  That said, 
beneficiaries registered few complaints about plan switching in the Part D performance 
data. 
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Limitations 
 This study is limited by the fact that the qualitative sample was composed of a 
convenience sample of beneficiaries and community support workers from a very 
specific agency context in the City of St. Louis, Missouri.  All three of the agencies from 
which participants were drawn have a reputation in the community for excellent case 
management services, which may have affected the findings.  Beneficiaries from these 
three agencies may receive more services, of a higher quality, than community mental 
health clients at other agencies or in other parts of the United States. 
 There were some limitations to the use of a volunteer sample for the focus groups 
and interviews.   Some of those who volunteered to participate in these groups and 
interviews were individuals who have had particularly negative experiences with 
Medicare, and who were looking for a forum in which they could air their complaint.  
Some participants may have offered to take part so that they could obtain the gift card, 
snacks, and bus passes that were offered to all who took part, even though they did not 
have particularly well-thought-out opinions about Medicare.  The author attempted to 
minimize this possibility by emphasizing in recruitment materials that participants needed 
to have experience with the Part D program, and that the research was focused on looking 
for perspectives and opinions about that program.   
 An additional limitation was that several of the focus groups were quite small, 
involving only two or three individuals.  However, Toner (2009), in a recent article on 
qualitative methods, has pointed out the value of very small focus groups in eliciting deep 
yet focused information from participants.  In addition, with participants who had a 
diagnosis of mental illness, smaller focus groups actually functioned extraordinarily well 
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and enabled interviewees to stay closer to the main topic of discussion and avoid 
unnecessary “detours” into other topics. 
 The quality of focus group and interview data was also affected by the fact that 
most of the consumer focus group and interview participants had significant thought 
disorders.  Though the majority of participants were able to stay on task and contribute to 
the data collection process in a clear and organized fashion, there were times when 
participants’ thought disorders affected the coherence of their speech.    Saavedra, Cubero 
& Crawford (2009) offer interesting insights into the coherence of the narratives of 
individuals with schizophrenia, and they point out that despite significant thought 
disorder, many individuals with schizophrenia are able to tell a narrative of their life 
experiences.  By transcribing focus groups and interviews shortly after conducting them, 
and by keeping groups small, the investigator was able to decipher participants’ 
narratives and understand their contribution to the process. 
Furthermore, the quantitative findings were limited by the small number of 
benchmark Part D plans available to Missouri beneficiaries in 2009.  With only six plans 
to compare, the ability to draw conclusions about benchmark plans is constrained.  The 
limited variability in the plan attributes also affected the ability to analyze these data in a 
meaningful way. 
Implications for Social Work Research 
 The finding in this study that most beneficiaries are quite satisfied with their Part 
D benefits is counterintuitive, when compared with the predictions of Medicare advocacy 
groups (MRC, 2005) and the observations of psychiatrists who have been surveyed about 
Part D (West et al., 2007; West et al., 2009).  Therefore, there needs to be further study of 
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dually-eligible Medicare beneficiaries with mental illness, to examine more thoroughly 
the reasons for their high level of satisfaction with Part D.  It would be useful to 
undertake a broader survey of beneficiaries with mental illness, so that broader trends in 
Part D could be examined.  The findings of this study are limited by their geographic 
specificity; use of a Medicare beneficiary survey to collect more representative data on 
mentally ill beneficiaries’ satisfaction would provide valuable insights. 
 In addition, research needs to be conducted to determine whether dually-eligible 
older adult beneficiaries with mental illness have different needs than younger Medicare 
beneficiaries disabled by mental illness.  The sample in this particular study included 
mostly beneficiaries under age 65; older adult beneficiaries with mood disorders or 
schizophrenia may have different needs, especially related to medical co-morbidity.  
Studies of older adult Medicare beneficiaries have not attempted to disentangle the 
experiences of beneficiaries with mental illnesses from the larger population of elderly 
Medicare participants. 
Another implication for social work research is that the role of social workers in 
assisting mentally ill beneficiaries with their Part D benefits needs to be more adequately 
studied.  The Mental Health Part D Web site discusses the importance of community case 
managers, residential and inpatient staff, and assertive community treatment team 
members in accessing and utilizing Part D benefits for adults with mental illness, but the 
exact roles and tasks undertaken by these professionals, many of whom are social 
workers, have gone unstudied until now.   This study found that St. Louis-area 
community support workers and case managers were very active in a variety of tasks 
related to accessing medication, medication adherence, and use of insurance programs.  
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Further study of social workers’ roles regarding access to Part D, as well as the 
pharmacological management of mental illness, would be useful. 
Research also needs to be conducted to determine how much social workers and 
other community-based case managers know about the Medicare Part D benefit.  Ferri 
and Cox (2009) discovered that social work students were not very knowledgeable 
regarding the Medicare prescription drug program.  It would be useful to survey social 
workers and case managers in community settings to assess their knowledge and 
understand where gaps in program understanding may be occurring.  This would greatly 
enhance efforts to educate community-based mental health professionals about the use of 
the Part D program. 
In addition, patient-centered care principles should be used more frequently in 
social work research.  Though “client-centered care” is occasionally mentioned in the 
social work literature (Jindani & Murdock, 2009), the principles of patient-centered care 
as they are described in the health care literature are relevant to social workers.  Patient-
centered care is applicable to many typical social work roles, such as advocacy, care 
coordination, and rehabilitation services.  Patient-centered care can be used not only in 
health services and health policy research, but also as a tool for assessing social service 
and mental health programs dominated by social work professionals.  Leplege et al. 
(2007) have mentioned that non-medical mental health professionals have shied away 
from the term “patient-centered care.”  Nonetheless, social work and psychiatric 
rehabilitation professionals should embrace the principles underlying the concept of 
patient-centered care and use them to evaluate the quality of community mental health 
services. 
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Implications for Health Care Policy 
 It appears that Medicare Part D is here to stay (Kaiser Family Foundation, 2010).  
The new health reform law includes a few provisions related to Part D, the most 
important of which is probably the effort to close the “doughnut hole” coverage gap over 
the next several years.  This will likely have little impact on dually-eligible beneficiaries, 
however, as they already have low-income subsidy assistance in the coverage gap.  For 
beneficiaries with slightly higher incomes, the closing of the “doughnut hole” will be 
extremely helpful, as it will reduce out-of-pocket costs for these individuals. 
 The newly-initiated efforts within the Centers for Medicare and Medicaid 
Services to coordinate Medicare and Medicaid benefits have the potential to improve 
access to coverage for many dually-eligible beneficiaries (Kaiser Family Foundation, 
2010).  Coordination of benefits provided by the Medicare and Medicaid program could 
lead to better coverage and fewer gaps such as the current gap in dental care for low-
income beneficiaries.  It could also help ensure that at least some drugs not covered by 
Medicare Part D will be paid for by the Medicaid program.  The Centers for Medicare 
and Medicaid Services do need to take constructive action to ensure better coordination 
between the Medicare and Medicaid programs.  At present, the coordination of these 
programs is largely left in the hands of community professionals and helpers; better 
organization on the system level would take a large burden off of case managers and 
pharmacists. 
 The Centers for Medicare and Medicaid Services also need to take action to 
ensure better information and communication from Part D plans to stakeholders.  
Advertisements for Part D plans and Medicare Advantage plans need to be monitored and 
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clearly identified as advertising, so that beneficiaries do not switch plans or dis-enroll 
from a plan because they believe they are “required” to do so.  Too much of the current 
advertising appears in a form that is interpreted by beneficiaries as a directive from the 
Medicare program. 
 Furthermore, the level of health literacy of beneficiaries needs to be taken into 
account in Medicare communications.  The Centers for Medicare and Medicaid Services 
need to recognize that terms such as “catastrophic” and “benchmark” may confuse 
beneficiaries.  Reading levels of Medicare materials must be brought down, and at the 
same time, CMS needs to undertake community-level efforts to improve the health 
literacy of lower-income Medicare beneficiaries. 
Implications for Social Work Policy and Practice 
Clients need help to use this benefit.  The nature of the paperwork and the 
language used by benefit plans are such that the average citizen has a hard time 
understanding them (Cummings, Rice, & Hanoch, 2009).  In the stakeholder focus 
groups, not only beneficiaries but also community support workers expressed their 
difficulties in comprehending the Part D paperwork.  In addition, low-income 
beneficiaries did not have extensive computer access, so Web-based tools and 
information, on which community support workers were reliant for knowledge of the Part 
D benefit, were not available or particularly helpful to beneficiaries.  Beneficiaries with 
disabilities are likely to face similar problems as older adults experience in using the 
Medicare Web site, so resources need to be more accessible (Czaja, Sharit, & Nair, 
2008).  Research on computer use among the elderly has confirmed that those with 
disabilities and those with lower incomes have less access to computers (Wright & Hill, 
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2009).  For adequate information, communication, and education to be provided to 
beneficiaries and their helpers, print resources need to be available to beneficiaries.  
Printed materials should be distributed through community mental health agencies, in 
addition to being mailed to beneficiaries.  Furthermore, greater computer/Internet access 
needs to be provided to mental health consumers in clubhouse settings. 
Web-based resources should be more broadly promoted among community 
support workers and nurse-case managers, so that they can use these tools to help their 
clients obtain what they need from the Part D program.  There are many Web sites with 
valuable information about accessing the Part D benefit, not only the official Medicare 
Web site, but also a number of informational Web sites sponsored by non-profit 
organizations and advocacy groups.  These resources need to be more widely publicized 
so that community-based mental health professionals can more easily take advantage of 
them. 
Furthermore, there needs to be a mechanism for paying for community-based 
service coordination for dually-eligible beneficiaries with mental or cognitive conditions.  
Part D provides a mechanism for pharmacists to be reimbursed for medication therapy 
management (MTM) services to Medicare beneficiaries with chronic conditions, but 
many pharmacists do not take advantage of this source of payment.  This may be in part 
because they view MTM as a way for the Medicare program to contain costs, rather than 
as a mechanism for effective and compassionate service provision to medically 
vulnerable beneficiaries.  In addition, there is no provision for social workers or other 
community providers to be paid for the work that they do in coordinating prescription 
drug benefits (Kravitz & Chang, 2005).  It is not clear whether Medicare Part D should 
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pay for this service, or whether funding should come from another federal or state source.  
Currently, the services of community support workers at mental health agencies are 
largely financed through Medicaid.  The examination of patient-centered care principles 
in the Part D program illustrates the tremendous importance of care continuity and 
emotional support.  Community-based service coordination should be reimbursed 
(National Health Council, 2009; Thorpe et al., 2010). 
The services of State Health Insurance Assistance (SHIP) programs, at least in the 
state of Missouri, need to be more broadly promoted.  Stakeholders, be they beneficiaries 
or their helpers, do not know where to go to get help related to Part D.  Not a single focus 
group or interview participant mentioned Missouri CLAIM (Community Leaders 
Assisting the Insured of Missouri; Missouri’s SHIP program) as a source of information 
about Part D.  Collaboration between the CLAIM program and community mental health 
agencies, similar to the collaborations between the CLAIM program and agencies that 
serve the elderly and people with physical disabilities should be encouraged.  CLAIM 
may even be able to train volunteer counselors from mental health agencies, as they have 
done with volunteers from agencies for the aging.  This would lead to greater education 
and empowerment—key aspects of patient-centered care. 
 “Smart” methods of assigning benchmark plans to low-income beneficiaries must 
be used, so that beneficiaries and their helpers do not have to spend a great deal of time 
and energy determining whether the prescription drug plan to which the beneficiary has 
been randomly assigned is the best fit for him/her or not (Summer et al., 2008).  The 
switching process should not be as burdensome to beneficiaries as it is under the current 
system of re-assigning prescription drug plans.  This would contribute greatly to the 
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patient-centeredness of the Part D program, by promoting coordination of care as well as 
continuity and secure transitions (Neuman & Cubanski, 2009). 
Implications for Social Work Education 
It is clear from this study that generalist social workers, those who are likely to be 
in case management positions helping adults with mental illness, need a thorough 
knowledge of Medicare.  It needs to be stressed in bachelor’s- and master’s-level social 
policy courses that Medicare is not just the territory of the elderly, but an important 
resource to many men and women with permanent disabilities.  Education of generalist 
social workers also needs to emphasize the fact that low-income Medicare beneficiaries 
are more likely to have serious mental illness than higher-income beneficiaries.  Current 
research indicates that social work students do not know very much about Medicare Part 
D; this situation needs to be addressed in social work curricula (Ferri & Cox, 2009). 
Another implication for social work education is that there is a need, more than 
ever, for social workers to be able to communicate across health care disciplines.  Case 
managers are often in the position of having to communicate about clients’ medication  
needs with nurses, pharmacists, and physicians, and the ability to “speak a common 
language” affects the case manager’s ability to meet the client’s needs. 
The important role of social workers in medication access and adherence has not 
been stressed enough in social work education or in the professional literature.  Case 
managers not only assist people with benefits information and statements from their 
prescription drug plans; they are also helping people to obtain their medications and 
filling medicine planners.  Graduate social workers in particular need knowledge of 
psychopharmacology and health care policy to be effective in their community roles.  
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Further examination is needed of the roles social workers play in medication adherence in 
the community.  As Pedan et al. (2009) have stated, health care providers have a 
responsibility to raise awareness among their clients regarding their prescription drug 
coverage and costs; educating social workers for this role is essential. 
The knowledge generated in this study will not only advance our understanding of 
the Medicare prescription drug benefit as it has been implemented thus far, but will also 
help researchers and policy-makers to understand how Medicare policy can be reformed 
to better serve the needs of adults with serious mental illness.  A better knowledge of 
stakeholders’ priorities and an accurate understanding of the patient-centeredness of the 
various Part D plans will enable policy-makers to undertake legislative and regulatory 
changes that can make this program work better for some of its most vulnerable 
beneficiaries. 
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